<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12049548</article-id><article-id pub-id-type="pmcid-ver">PMC12049548.1</article-id><article-id pub-id-type="pmcaid">12049548</article-id><article-id pub-id-type="pmcaiid">12049548</article-id><article-id pub-id-type="pmid">40319121</article-id><article-id pub-id-type="doi">10.1038/s41598-025-99698-y</article-id><article-id pub-id-type="publisher-id">99698</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Designing and characterizing first Iranian study evaluating serum levels of lithium in patients for population pharmacokinetics (FIRELOLIPOP): baseline and first report</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Khakshoor</surname><given-names initials="MM">Mohammad Mahdi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Pariz</surname><given-names initials="N">Naser</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Askari</surname><given-names initials="VR">Vahid Reza</given-names></name><address><email>askariv@mums.ac.ir</email><email>vahidrezaaskary@gmail.com</email><email>vahidrezaaskari@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fayyazi Bordbar</surname><given-names initials="MR">Mohammad Reza</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Honari</surname><given-names initials="S">Sara</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shirazinia</surname><given-names initials="M">Matin</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baradaran Rahimi</surname><given-names initials="V">Vafa</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Naghibi Sistani</surname><given-names initials="MB">Mohammad Bagher</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00g6ka752</institution-id><institution-id institution-id-type="GRID">grid.411301.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0666 1211</institution-id><institution>Department of Electrical Engineering, Faculty of Engineering, </institution><institution>Ferdowsi University of Mashhad, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04sfka033</institution-id><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Clinical Research Development Unit, Imam Reza Hospital, Faculty of Medicine, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04sfka033</institution-id><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Psychiatry and Behavioral Sciences Research Center, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04sfka033</institution-id><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Faculty of Medicine, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04sfka033</institution-id><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Department of Cardiovascular Diseases, Faculty of Medicine, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478255</issue-id><elocation-id>15514</elocation-id><history><date date-type="received"><day>1</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>05</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-05 00:25:48.130"><day>05</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2025_Article_99698.pdf"/><abstract id="Abs1"><p id="Par1">Bipolar disorder (BD) is a chronic psychiatric illness characterized by recurrent manic and depressive episodes, leading to significant impairment. Lithium remains a key treatment for BD, particularly in relapse prevention. However, its narrow therapeutic range and inter-individual pharmacokinetic variability necessitate careful dosing. This study aims to establish a suitable platform to investigate the pharmacokinetics of lithium in hospitalized patients with BD in Mashhad, Iran, to optimize therapeutic use and minimize toxicity. This cross-sectional study was conducted at Ibn Sina Hospital, Mashhad, between 2016 and 2022. Hospitalized patients diagnosed with BD and receiving lithium therapy were included. Clinical, demographic, and laboratory data were collected, including lithium serum levels, renal function parameters, and co-administered medications. Advanced data pre-processing techniques were applied to ensure accuracy and facilitate future pharmacokinetic modeling. A total of 701 patients (53.1% male, mean age: 38.0 SD: &#177; 12.2 years) with 795 hospitalization episodes were analyzed. The mean lithium serum concentration was 0.65&#8201;&#177;&#8201;0.30 mEq/L. Thyroid disorders (5.9%) and diabetes (5.6%) were the most common comorbidities. The mean duration of hospitalization during lithium treatment was 21.7&#8201;&#177;&#8201;10.8 days. Sodium valproate was the most frequently co-prescribed medication (<italic toggle="yes">n</italic>&#8201;=&#8201;553), followed by lorazepam (<italic toggle="yes">n</italic>&#8201;=&#8201;468) and risperidone (<italic toggle="yes">n</italic>&#8201;=&#8201;458). Lithium dosing showed considerable variability, emphasizing the need for individualized therapeutic strategies. This study provides valuable insights into lithium pharmacokinetics in Iranian BD patients. The findings highlight the necessity of personalized dosing approaches to enhance efficacy and reduce adverse effects. Future research should incorporate pharmacokinetic modeling and machine learning to refine lithium therapy.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-025-99698-y.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Bipolar disorder</kwd><kwd>Lithium</kwd><kwd>Pharmacokinetics</kwd><kwd>Therapeutic drug monitoring</kwd><kwd>Personalized medicine</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Psychiatric disorders</kwd><kwd>Molecular biology</kwd><kwd>Neuroscience</kwd><kwd>Psychology</kwd><kwd>Risk factors</kwd><kwd>Biologics</kwd><kwd>Biomarkers</kwd><kwd>Drug safety</kwd><kwd>Target validation</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004748</institution-id><institution>Mashhad University of Medical Sciences</institution></institution-wrap></funding-source><award-id>4011114</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Bipolar disorder (BD), characterized by alternating episodes of mania and depression, is one of the most severe psychiatric conditions, often leading to significant occupational, cognitive, social, and emotional impairments<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. Clinically, BD is categorized into two main subtypes: type I, marked by distinct manic episodes, and type II, defined by hypomanic episodes alongside major depressive episodes<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. The global prevalence of BD has increased significantly, rising from 24.8&#160;million cases in 1990 to 39.5&#160;million cases in 2019. Among mental disorders, BD ranks as the fourth leading cause of years lived with disability (YLDs) and disability-adjusted life years (DALYs) across all age groups, following depressive disorders, anxiety disorders, and schizophrenia. Moreover, it ranks as the third cause of DALYs and YLDs rates in the 15&#8211;24 years age group<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>.</p><p id="Par3">A manic episode is considered a medical emergency that requires immediate treatment to prevent self-harm or harm to others. The recommended approach for adults experiencing acute manic symptoms involves pharmacological intervention. Several agents, including sodium valproate, lithium, and antipsychotics, have demonstrated sufficient efficacy in managing such episodes<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Once the acute mood disturbances subside, most patients require prolonged medical treatment, often lasting several years. Lithium becomes a cornerstone therapy in this stage, known as maintenance treatment. Lithium has shown greater efficacy than sodium valproate in preventing relapses of acute episodes<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. As a result, lithium is recognized as one of the foundational treatments in bipolar disorder management guidelines<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>.</p><p id="Par4">Following lithium oral administration, the immediate-release form is absorbed rapidly and effectively through the upper gastrointestinal tract within 1&#8211;6&#160;h<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Lithium is mainly absorbed on the jejunum and ileum<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> and its absorption can be influenced by dietary factors<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Once absorbed, lithium dissociates completely and circulates as a free cation in plasma, without binding to plasma proteins<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>. Due to its physicochemical properties and small molecular size, lithium distributes extensively across both extracellular and intracellular fluid compartments. However, its movement from the extracellular to intracellular space is relatively slow, attributed to a low diffusion coefficient across cell membranes. The volume of distribution for lithium has been reported to range between 0.8 and 1.2&#160;L/kg<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>.</p><p id="Par5">Lithium undergoes minimal metabolic transformation, as it bypasses hepatic metabolism. Approximately 2% of lithium is excreted via bile within 24&#160;h of oral administration<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. The drug is primarily eliminated as a free cation in the urine through glomerular filtration, with approximately 80% of the filtered lithium reabsorbed in the proximal tubule<sup><xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref></sup>. In individuals with normal renal function, including patients with bipolar disorder, the terminal elimination half-life (t&#189;) ranges from 16 to 30&#160;h<sup><xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR24">24</xref></sup>. Lithium clearance demonstrates considerable interindividual variability, with reported rates ranging from 0.6 to 2.4&#160;L/h<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>. Several physiological and pathological factors, such as age, total body weight, and renal function, affect total body clearance<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p><p id="Par6">Due to lithium&#8217;s narrow therapeutic window, careful monitoring of serum levels is essential to ensure both efficacy and safety. Therapeutic concentrations range from 0.6 to 1.5 mEq/L for acute mania and 0.6 to 0.8 mEq/L for maintenance therapy<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Serum levels exceeding 1.5 mEq/L can lead to toxicity, with early symptoms including gastrointestinal disturbances (e.g., nausea, vomiting, diarrhea), followed by neurological complications such as tremor, confusion, slurred speech, and agitation<sup><xref ref-type="bibr" rid="CR27">27</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref></sup>. Other lithium side effects include seizures, loss of appetite, muscle weakness, and an increase in urine volume<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Therefore, accurate dose adjustment is crucial to minimize adverse effects while maintaining therapeutic benefit<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p><p id="Par7">Safety, efficacy, and accurate dose determination of the drugs are some concerns that have been always exist since drug discovery and development. Population pharmacokinetics (PK) is one of the proposed solutions to overcome these concerns<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Population PK means investigating and evaluating the differences in plasma concentrations of the drugs between different people receiving the same standard drug regimen. Age, weight, and gender can be mentioned among the factors examined in these studies. It is important to put these factors together and predict an accurate dose for each person especially for those drugs that have a narrow therapeutic window. In this way, it is possible to reduce the costs of therapeutic drug monitoring, drug side effects due to dose increase, or response reduction due to dose reduction<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>.</p><p id="Par8">Several physiological and pathological factors influence lithium pharmacokinetics, including age, renal function, body weight, circadian rhythm, genetic factors, cardiovascular conditions, pregnancy, and lactation<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. Studies have also indicated that genetic factors are linked to bipolar disorder, particularly with regard to the age of onset. These findings suggest that genetic factors may influence the progression of the disease and play a significant role in shaping its course, leading to important differences in modeling<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Most of these factors affect the lithium PK through their impact on kidney function<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Despite the existing body of evidence regarding the PK of lithium, there are some controversies surrounding this issue<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. For instance, the optimal lithium dose for managing BD type II is unclear<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Levels effective for acute mania are not always suitable for type II BD, and many clinicians believe that lower serum levels, typically 0.4&#8211;0.8 mmol/L, may still be adequate. Additionally, while the lithium therapeutic range has been extensively studied, there is debate over the best dosing regimen. Some experts recommend a once-daily dosage, while others favor dividing the daily dose into two or three smaller doses. Those supporting a once-daily regimen highlight lithium&#8217;s mean half-life of 24&#160;h<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR41">41</xref>&#8211;<xref ref-type="bibr" rid="CR43">43</xref></sup>. Ultimately, lithium dosing should prioritize clinical response over achieving specific serum levels, as lower levels do not necessarily indicate subtherapeutic effects<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>.</p><p id="Par9">Given these complexities, we established the first Iranian registry dedicated to studying lithium pharmacokinetics in hospitalized patients with bipolar mood disorder. This article presents the baseline demographic and clinical characteristics of enrolled patients and outlines the methods and design of the FIRELOLIPOP study (First Iranian Registry Evaluating Lithium Levels for Population Pharmacokinetics), marking an initial step toward individualized lithium therapy in Iranian clinical practice.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Method</title><p id="Par10">This is a cross-sectional study conducted between 2016 and 2022 at Ibn Sina Hospital in Mashhad, Iran, on hospitalized patients with bipolar disorder. Mashhad, the second most populous city in Iran, has a population of over 3&#160;million and is located in the east of the country. Ibn-Sina Hospital is also a reference center in the field of psychiatry and a referral center for bipolar patients in the east of the country. All procedures have been approved by the Mashhad University of Medical Sciences Ethical Committee (Ethical permission code: IR.MUMS.MEDICAL.REC.1401.485, permission date: 2022&#8211;11&#8211;08, Approval ID: 4011114). All methods were performed in accordance with the Mashhad University of Medical Sciences Ethical Committee guidelines and regulations (Ethical permission code: IR.MUMS.MEDICAL.REC.1401.485, permission date: 2022&#8211;11&#8211;08, Approval ID: 4011114).</p></sec><sec id="Sec4"><title>Inclusion criteria</title><p id="Par11">Patients with a confirmed diagnosis of BD who were prescribed lithium were included in the study. Patients were excluded if their serum lithium levels had not been measured or if they were hospitalized for less than five days. Patients hospitalized for fewer than 5 days were excluded to ensure that serum lithium concentrations reflect steady-state levels, which are typically reached after ~&#8201;5 days of regular dosing given lithium&#8217;s half-life of approximately 24&#160;h. The diagnosis of bipolar disorder in all patients was based on the ICD-10 code, which was made by a specialist physician. According to the International Classification of Diseases, 10th Revision (ICD-10), BD is coded under F31.0 to F31.9, encompassing a spectrum of clinical presentations including hypomanic, manic (with or without psychotic features), depressive, mixed episodes, and remission states<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. All details are given in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>.</p><p id="Par12">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Patients&#8217; inclusion and exclusion criteria.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e474" position="float" orientation="portrait" xlink:href="41598_2025_99698_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec5"><title>Data collection</title><p id="Par13">First, a list of patients was compiled based on ICD-10 codes between March 2016 and March 2022. These codes include nine different disease categories, ranging from F31.1 to F31.9, as defined by the ICD-10 classification. Subsequently, blood and urine test data&#8212;comprising approximately 100 tests&#8212;were extracted. However, since some tests had been performed on only a small number of patients and were not considered meaningful, only 28 relevant tests with a sufficient number of records were included in the dataset. These 28 tests consist of lithium, WBC, RBC, Hct, MCH, MCV, MCHC, PMN, Hb, lymphocytes, monocytes, platelets, eosinophils, potassium, sodium, creatinine, urea, SGPT (ALT), SGOT (AST), ALP, calcium, TSH, RDW-CV, Fe, TIBC, folic acid, serum magnesium, and albumin.</p><p id="Par14">All medications used by patients were extracted from the hospital registry system to check for their concurrence with lithium use. After initial reviews, the most important and most frequently used of them, 61 items, were entered into the data table. These medications, along with their standard dosages, are listed in Table&#160;<xref rid="Tab2" ref-type="table">1</xref>.</p><p id="Par15">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Drugs and calculated standard doses.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Drug</th><th align="left" colspan="1" rowspan="1">Dose</th><th align="left" colspan="1" rowspan="1">Drug</th><th align="left" colspan="1" rowspan="1">Dose</th><th align="left" colspan="1" rowspan="1">Drug</th><th align="left" colspan="1" rowspan="1">Dose</th><th align="left" colspan="1" rowspan="1">Drug</th><th align="left" colspan="1" rowspan="1">Dose</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Alprazolam</td><td align="left" colspan="1" rowspan="1">0.5&#160;mg</td><td align="left" colspan="1" rowspan="1">Clonidine</td><td align="left" colspan="1" rowspan="1">0.2&#160;mg</td><td align="left" colspan="1" rowspan="1">Levetiracetam</td><td align="left" colspan="1" rowspan="1">500&#160;mg</td><td align="left" colspan="1" rowspan="1">Propranolol</td><td align="left" colspan="1" rowspan="1">10&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Amantadine</td><td align="left" colspan="1" rowspan="1">100&#160;mg</td><td align="left" colspan="1" rowspan="1">Clozapine</td><td align="left" colspan="1" rowspan="1">25&#160;mg</td><td align="left" colspan="1" rowspan="1">Levothyroxine</td><td align="left" colspan="1" rowspan="1">0.05&#160;mg</td><td align="left" colspan="1" rowspan="1">Quetiapine</td><td align="left" colspan="1" rowspan="1">25&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Amitriptyline</td><td align="left" colspan="1" rowspan="1">10&#160;mg</td><td align="left" colspan="1" rowspan="1">Cobalamin</td><td align="left" colspan="1" rowspan="1">1000 mcg/ml</td><td align="left" colspan="1" rowspan="1">Lithium</td><td align="left" colspan="1" rowspan="1">300&#160;mg</td><td align="left" colspan="1" rowspan="1">Risperidone</td><td align="left" colspan="1" rowspan="1">1&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Aripiprazole</td><td align="left" colspan="1" rowspan="1">5&#160;mg</td><td align="left" colspan="1" rowspan="1">Cyproterone</td><td align="left" colspan="1" rowspan="1">50&#160;mg</td><td align="left" colspan="1" rowspan="1">Lorazepam</td><td align="left" colspan="1" rowspan="1">1&#160;mg</td><td align="left" colspan="1" rowspan="1">Sertraline</td><td align="left" colspan="1" rowspan="1">50&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Atorvastatin</td><td align="left" colspan="1" rowspan="1">20&#160;mg</td><td align="left" colspan="1" rowspan="1">Divalproex</td><td align="left" colspan="1" rowspan="1">250&#160;mg</td><td align="left" colspan="1" rowspan="1">Magnesium hydroxide</td><td align="left" colspan="1" rowspan="1">250&#160;mg</td><td align="left" colspan="1" rowspan="1">Thiamine</td><td align="left" colspan="1" rowspan="1">100&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Azithromycin</td><td align="left" colspan="1" rowspan="1">250&#160;mg</td><td align="left" colspan="1" rowspan="1">Fluconazole</td><td align="left" colspan="1" rowspan="1">150&#160;mg</td><td align="left" colspan="1" rowspan="1">Metformin</td><td align="left" colspan="1" rowspan="1">500&#160;mg</td><td align="left" colspan="1" rowspan="1">Tizanidine</td><td align="left" colspan="1" rowspan="1">4&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Biperiden</td><td align="left" colspan="1" rowspan="1">2&#160;mg</td><td align="left" colspan="1" rowspan="1">Fluoxetine</td><td align="left" colspan="1" rowspan="1">10&#160;mg</td><td align="left" colspan="1" rowspan="1">Methadone</td><td align="left" colspan="1" rowspan="1">5&#160;mg</td><td align="left" colspan="1" rowspan="1">Topiramate</td><td align="left" colspan="1" rowspan="1">25&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Bismuth</td><td align="left" colspan="1" rowspan="1">120&#160;mg</td><td align="left" colspan="1" rowspan="1">Flupentixol</td><td align="left" colspan="1" rowspan="1">20&#160;mg</td><td align="left" colspan="1" rowspan="1">Midazolam</td><td align="left" colspan="1" rowspan="1">5&#160;mg/ml</td><td align="left" colspan="1" rowspan="1">Trihexyphenidyl</td><td align="left" colspan="1" rowspan="1">2&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Bupropion</td><td align="left" colspan="1" rowspan="1">75&#160;mg</td><td align="left" colspan="1" rowspan="1">Fluphenazine</td><td align="left" colspan="1" rowspan="1">25&#160;mg</td><td align="left" colspan="1" rowspan="1">Naproxen</td><td align="left" colspan="1" rowspan="1">250&#160;mg</td><td align="left" colspan="1" rowspan="1">Valproate</td><td align="left" colspan="1" rowspan="1">200&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Calcium-D</td><td align="left" colspan="1" rowspan="1">500&#160;mg-200 IU</td><td align="left" colspan="1" rowspan="1">Folate</td><td align="left" colspan="1" rowspan="1">0.4&#160;mg</td><td align="left" colspan="1" rowspan="1">Olanzapine</td><td align="left" colspan="1" rowspan="1">5&#160;mg</td><td align="left" colspan="1" rowspan="1">Vitamin C</td><td align="left" colspan="1" rowspan="1">1000&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Carbamazepine</td><td align="left" colspan="1" rowspan="1">200&#160;mg</td><td align="left" colspan="1" rowspan="1">Furosemide</td><td align="left" colspan="1" rowspan="1">40&#160;mg</td><td align="left" colspan="1" rowspan="1">Omeprazole</td><td align="left" colspan="1" rowspan="1">20&#160;mg</td><td align="left" colspan="1" rowspan="1">Vitamin D</td><td align="left" colspan="1" rowspan="1">50,000 IU</td></tr><tr><td align="left" colspan="1" rowspan="1">Cefalexin</td><td align="left" colspan="1" rowspan="1">500&#160;mg</td><td align="left" colspan="1" rowspan="1">Gabapentin</td><td align="left" colspan="1" rowspan="1">100&#160;mg</td><td align="left" colspan="1" rowspan="1">Oxybutynin</td><td align="left" colspan="1" rowspan="1">5&#160;mg</td><td align="left" colspan="1" rowspan="1">Vitamin E</td><td align="left" colspan="1" rowspan="1">100 IU</td></tr><tr><td align="left" colspan="1" rowspan="1">Chlordiazepoxide</td><td align="left" colspan="1" rowspan="1">5&#160;mg</td><td align="left" colspan="1" rowspan="1">Glibenclamide</td><td align="left" colspan="1" rowspan="1">5&#160;mg</td><td align="left" colspan="1" rowspan="1">Pantoprazole</td><td align="left" colspan="1" rowspan="1">20&#160;mg</td><td align="left" colspan="1" rowspan="1">Zolpidem</td><td align="left" colspan="1" rowspan="1">5&#160;mg</td></tr><tr><td align="left" colspan="1" rowspan="1">Chlorpromazine</td><td align="left" colspan="1" rowspan="1">25&#160;mg</td><td align="left" colspan="1" rowspan="1">Haloperidol</td><td align="left" colspan="1" rowspan="1">5&#160;mg</td><td align="left" colspan="1" rowspan="1">Perphenazine</td><td align="left" colspan="1" rowspan="1">2&#160;mg</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Citalopram</td><td align="left" colspan="1" rowspan="1">20&#160;mg</td><td align="left" colspan="1" rowspan="1">Haloperidol</td><td align="left" colspan="1" rowspan="1">0.5&#160;mg</td><td align="left" colspan="1" rowspan="1">Phenobarbital</td><td align="left" colspan="1" rowspan="1">60&#160;mg</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Clonazepam</td><td align="left" colspan="1" rowspan="1">1&#160;mg</td><td align="left" colspan="1" rowspan="1">Lamotrigine</td><td align="left" colspan="1" rowspan="1">25&#160;mg</td><td align="left" colspan="1" rowspan="1">Promethazine</td><td align="left" colspan="1" rowspan="1">50&#160;mg</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr></tbody></table></table-wrap>
</p><p id="Par17">Then, the patient&#8217;s clinical and demographic data were collected using a predetermined checklist, including height, weight, age, gender, marital status, personal and family history of mental illness, drug, alcohol, and smoking history, blood pressure, medical and surgical history, first episode of mental illness, number of days of hospitalization, address of birth and residence, nationality, and other such items. Variables such as BMI, GFR, and several other composite variables were also added to the data.</p></sec><sec id="Sec6"><title>Extracting, integrating, and controlling data quality</title><p id="Par18">The medical staff carefully collected all data, and various stages of data engineering were performed under the supervision of an artificial intelligence expert. This process included various parts, including quality review, merging different data tables, effective and understandable data arrangement, process simplification, completion of incomplete data, and removal of existing anomalies. All the characteristics and different periods of tests and medications were recorded in one Excel row and for a specific time period for each patient so that in the future, other specialists who do not know data science or database management could easily use this data to expand their knowledge and research.</p><p id="Par19">Also, pre-processing was done to understand the data better and help remove existing obstacles and shortcomings. Advanced tools and software such as Python<sup>&#174;</sup> and RapidMiner<sup>&#174;</sup> were used for pre-processing, joining, monitoring, and ensuring the quality of the data to minimize any bias and implausible data. Python were extensively utilized for various tasks, including aligning different graphs, consolidating multiple tables into a single unified table, verifying and validating data placement, detecting noise and resolving it with expert consultation, as well as performing data structuring and engineering. Additionally, RapidMiner software facilitated a deeper understanding of the dataset through diverse visualization techniques, which proved valuable for writing articles and advancing the research. Furthermore, the software greatly assisted researchers in refining the dataset by detecting subtle errors and noise, performing data transformations, identifying outliers, and enhancing data quality through its advanced preprocessing and machine learning algorithms.</p></sec><sec id="Sec100"><title>Statistical analysis</title><p id="Par20">Continuous data were summarized using mean, minimum, maximum, and standard deviation, while categorical data were presented as frequencies and percentages. Chi-squared and Fisher&#8217;s exact tests were employed to compare demographic characteristics across different types of BD based on ICD-10 classification. A p-value of less than 0.05 was considered statistically significant.</p></sec></sec><sec id="Sec8"><title>Results</title><p id="Par21">Between March 2016 and March 2022, a total of 7828 patients (12196 episodes) were admitted to our center with a diagnosis of BD, of whom only 2093 patients were treated with lithium during their hospitalizations. Lithium concentration results were only recorded in the data repository after March 2019, which limited the study sample to this period. Ultimately, 701 distinct patients with 795 admission episodes were included in this study (Supplementary Tables S1-S4). The concentration-time graph of serum lithium level for all admissions is shown in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>.</p><p id="Par22">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Concentration-time graph of serum lithium level for all admissions (<italic toggle="yes">n</italic>&#8201;=&#8201;795).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e823" position="float" orientation="portrait" xlink:href="41598_2025_99698_Fig2_HTML.jpg"/></fig>
</p><sec id="Sec9"><title>Patients&#8217; characteristics</title><p id="Par23">Of the 701 patients included, 372 (53.1%) were male, with a mean age of 38.02 years (&#177;&#8201;12.21) (Table&#160;<xref rid="Tab3" ref-type="table">2</xref>). A total of 361 patients (51.5%) were married, 225 (32.1%) were single, and 422 (60.2%) were residents of Mashhad. Regarding diagnostic categories, 154 patients (22.0%) were classified under F31.1, 153 (21.8%) under F31.2, 42 (6.0%) under F31.3 to F31.8, and 352 (50.2%) under F31.9. The mean body mass index (BMI) of the patients was 25.91&#160;kg/m<sup>2</sup> (&#177;&#8201;5.71), with a mean height of 166.03&#160;cm (&#177;&#8201;9.60) and a mean weight of 71.39&#160;kg (&#177;&#8201;16.41). The estimated glomerular filtration rate (eGFR), calculated using the Cockcroft-Gault, CKD-EPI, and MDRD formulas, was 100.60 mL/min/1.73&#160;m<sup>2</sup> (&#177;&#8201;28.67), 93.47 mL/min/1.73&#160;m&#178; (&#177;&#8201;17.83), and 80.80 mL/min/1.73&#160;m<sup>2</sup> (&#177;&#8201;18.55), respectively.</p><p id="Par24">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Patient characteristics - quantitative values.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="2">Title</th><th align="left" rowspan="2" colspan="1">Age</th><th align="left" rowspan="2" colspan="1">Day</th><th align="left" rowspan="2" colspan="1">Real_Day</th><th align="left" rowspan="2" colspan="1">Height</th><th align="left" rowspan="2" colspan="1">Weight</th><th align="left" rowspan="2" colspan="1">BMI</th><th align="left" colspan="3" rowspan="1">GFR</th></tr><tr><th align="left" colspan="1" rowspan="1">MDRD</th><th align="left" colspan="1" rowspan="1">CKD</th><th align="left" colspan="1" rowspan="1">Cockcroft-Gault</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">Total</td><td align="left" colspan="1" rowspan="1">
<bold>Min</bold>
</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">140</td><td align="left" colspan="1" rowspan="1">35</td><td align="left" colspan="1" rowspan="1">14.5</td><td align="left" colspan="1" rowspan="1">39.23</td><td align="left" colspan="1" rowspan="1">43.63</td><td char="." align="char" colspan="1" rowspan="1">42.13</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Max</bold>
</td><td align="left" colspan="1" rowspan="1">78</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">195</td><td align="left" colspan="1" rowspan="1">141</td><td align="left" colspan="1" rowspan="1">56.5</td><td align="left" colspan="1" rowspan="1">264.29</td><td align="left" colspan="1" rowspan="1">156.25</td><td char="." align="char" colspan="1" rowspan="1">217.50</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Avg</bold>
</td><td align="left" colspan="1" rowspan="1">38.02</td><td align="left" colspan="1" rowspan="1">27.71</td><td align="left" colspan="1" rowspan="1">21.66</td><td align="left" colspan="1" rowspan="1">166.03</td><td align="left" colspan="1" rowspan="1">71.39</td><td align="left" colspan="1" rowspan="1">25.91</td><td align="left" colspan="1" rowspan="1">80.80</td><td align="left" colspan="1" rowspan="1">93.47</td><td char="." align="char" colspan="1" rowspan="1">100.60</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sd</bold>
</td><td align="left" colspan="1" rowspan="1">12.21</td><td align="left" colspan="1" rowspan="1">11.40</td><td align="left" colspan="1" rowspan="1">10.80</td><td align="left" colspan="1" rowspan="1">9.60</td><td align="left" colspan="1" rowspan="1">16.41</td><td align="left" colspan="1" rowspan="1">5.71</td><td align="left" colspan="1" rowspan="1">18.55</td><td align="left" colspan="1" rowspan="1">17.83</td><td char="." align="char" colspan="1" rowspan="1">28.67</td></tr><tr><td align="left" rowspan="4" colspan="1">Male</td><td align="left" colspan="1" rowspan="1">
<bold>Min</bold>
</td><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">150</td><td align="left" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">15.4</td><td align="left" colspan="1" rowspan="1">39.23</td><td align="left" colspan="1" rowspan="1">43.63</td><td char="." align="char" colspan="1" rowspan="1">42.13</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Max</bold>
</td><td align="left" colspan="1" rowspan="1">78</td><td align="left" colspan="1" rowspan="1">67</td><td align="left" colspan="1" rowspan="1">66</td><td align="left" colspan="1" rowspan="1">195</td><td align="left" colspan="1" rowspan="1">135</td><td align="left" colspan="1" rowspan="1">44.1</td><td align="left" colspan="1" rowspan="1">264.29</td><td align="left" colspan="1" rowspan="1">156.25</td><td char="." align="char" colspan="1" rowspan="1">217.50</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Avg</bold>
</td><td align="left" colspan="1" rowspan="1">38.98</td><td align="left" colspan="1" rowspan="1">28.54</td><td align="left" colspan="1" rowspan="1">21.55</td><td align="left" colspan="1" rowspan="1">172.71</td><td align="left" colspan="1" rowspan="1">74.84</td><td align="left" colspan="1" rowspan="1">25.05</td><td align="left" colspan="1" rowspan="1">86.12</td><td align="left" colspan="1" rowspan="1">98.26</td><td char="." align="char" colspan="1" rowspan="1">106.99</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sd</bold>
</td><td align="left" colspan="1" rowspan="1">12.43</td><td align="left" colspan="1" rowspan="1">10.99</td><td align="left" colspan="1" rowspan="1">10.37</td><td align="left" colspan="1" rowspan="1">7.05</td><td align="left" colspan="1" rowspan="1">14.57</td><td align="left" colspan="1" rowspan="1">4.40</td><td align="left" colspan="1" rowspan="1">19.42</td><td align="left" colspan="1" rowspan="1">17.23</td><td char="." align="char" colspan="1" rowspan="1">29.96</td></tr><tr><td align="left" rowspan="4" colspan="1">Female</td><td align="left" colspan="1" rowspan="1">
<bold>Min</bold>
</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">140</td><td align="left" colspan="1" rowspan="1">35</td><td align="left" colspan="1" rowspan="1">14.5</td><td align="left" colspan="1" rowspan="1">42.53</td><td align="left" colspan="1" rowspan="1">48.56</td><td char="." align="char" colspan="1" rowspan="1">45.77</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Max</bold>
</td><td align="left" colspan="1" rowspan="1">70</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">185</td><td align="left" colspan="1" rowspan="1">141</td><td align="left" colspan="1" rowspan="1">56.5</td><td align="left" colspan="1" rowspan="1">140.41</td><td align="left" colspan="1" rowspan="1">135.04</td><td char="." align="char" colspan="1" rowspan="1">202.58</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Avg</bold>
</td><td align="left" colspan="1" rowspan="1">36.93</td><td align="left" colspan="1" rowspan="1">26.78</td><td align="left" colspan="1" rowspan="1">21.80</td><td align="left" colspan="1" rowspan="1">159.39</td><td align="left" colspan="1" rowspan="1">67.96</td><td align="left" colspan="1" rowspan="1">26.76</td><td align="left" colspan="1" rowspan="1">74.84</td><td align="left" colspan="1" rowspan="1">88.10</td><td char="." align="char" colspan="1" rowspan="1">94.36</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sd</bold>
</td><td align="left" colspan="1" rowspan="1">11.87</td><td align="left" colspan="1" rowspan="1">11.77</td><td align="left" colspan="1" rowspan="1">11.27</td><td align="left" colspan="1" rowspan="1">6.79</td><td align="left" colspan="1" rowspan="1">17.39</td><td align="left" colspan="1" rowspan="1">6.66</td><td align="left" colspan="1" rowspan="1">15.48</td><td align="left" colspan="1" rowspan="1">16.94</td><td char="." align="char" colspan="1" rowspan="1">25.87</td></tr><tr><td align="left" rowspan="4" colspan="1">F31.1</td><td align="left" colspan="1" rowspan="1">
<bold>Min</bold>
</td><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">141</td><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">14.5</td><td align="left" colspan="1" rowspan="1">45.52</td><td align="left" colspan="1" rowspan="1">51.18</td><td char="." align="char" colspan="1" rowspan="1">52.97</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Max</bold>
</td><td align="left" colspan="1" rowspan="1">75</td><td align="left" colspan="1" rowspan="1">62</td><td align="left" colspan="1" rowspan="1">56</td><td align="left" colspan="1" rowspan="1">195</td><td align="left" colspan="1" rowspan="1">141</td><td align="left" colspan="1" rowspan="1">56.5</td><td align="left" colspan="1" rowspan="1">152.42</td><td align="left" colspan="1" rowspan="1">139.55</td><td char="." align="char" colspan="1" rowspan="1">200.00</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Avg</bold>
</td><td align="left" colspan="1" rowspan="1">38.13</td><td align="left" colspan="1" rowspan="1">26.10</td><td align="left" colspan="1" rowspan="1">21.12</td><td align="left" colspan="1" rowspan="1">165.06</td><td align="left" colspan="1" rowspan="1">72.67</td><td align="left" colspan="1" rowspan="1">26.73</td><td align="left" colspan="1" rowspan="1">79.39</td><td align="left" colspan="1" rowspan="1">92.11</td><td char="." align="char" colspan="1" rowspan="1">101.66</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sd</bold>
</td><td align="left" colspan="1" rowspan="1">12.61</td><td align="left" colspan="1" rowspan="1">10.56</td><td align="left" colspan="1" rowspan="1">9.94</td><td align="left" colspan="1" rowspan="1">9.96</td><td align="left" colspan="1" rowspan="1">17.94</td><td align="left" colspan="1" rowspan="1">6.47</td><td align="left" colspan="1" rowspan="1">17.08</td><td align="left" colspan="1" rowspan="1">17.63</td><td char="." align="char" colspan="1" rowspan="1">28.07</td></tr><tr><td align="left" rowspan="4" colspan="1">F31.2</td><td align="left" colspan="1" rowspan="1">
<bold>Min</bold>
</td><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">150</td><td align="left" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">16.5</td><td align="left" colspan="1" rowspan="1">42.55</td><td align="left" colspan="1" rowspan="1">50.00</td><td char="." align="char" colspan="1" rowspan="1">50.76</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Max</bold>
</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">65</td><td align="left" colspan="1" rowspan="1">65</td><td align="left" colspan="1" rowspan="1">190</td><td align="left" colspan="1" rowspan="1">121</td><td align="left" colspan="1" rowspan="1">48.5</td><td align="left" colspan="1" rowspan="1">140.41</td><td align="left" colspan="1" rowspan="1">129.29</td><td char="." align="char" colspan="1" rowspan="1">184.72</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Avg</bold>
</td><td align="left" colspan="1" rowspan="1">39.03</td><td align="left" colspan="1" rowspan="1">30.49</td><td align="left" colspan="1" rowspan="1">23.60</td><td align="left" colspan="1" rowspan="1">167.50</td><td align="left" colspan="1" rowspan="1">72.03</td><td align="left" colspan="1" rowspan="1">25.62</td><td align="left" colspan="1" rowspan="1">80.63</td><td align="left" colspan="1" rowspan="1">93.53</td><td char="." align="char" colspan="1" rowspan="1">101.95</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sd</bold>
</td><td align="left" colspan="1" rowspan="1">11.76</td><td align="left" colspan="1" rowspan="1">10.60</td><td align="left" colspan="1" rowspan="1">10.80</td><td align="left" colspan="1" rowspan="1">9.70</td><td align="left" colspan="1" rowspan="1">15.74</td><td align="left" colspan="1" rowspan="1">5.12</td><td align="left" colspan="1" rowspan="1">16.40</td><td align="left" colspan="1" rowspan="1">17.16</td><td char="." align="char" colspan="1" rowspan="1">26.93</td></tr><tr><td align="left" rowspan="4" colspan="1">F31.9</td><td align="left" colspan="1" rowspan="1">
<bold>Min</bold>
</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">140</td><td align="left" colspan="1" rowspan="1">35</td><td align="left" colspan="1" rowspan="1">15.2</td><td align="left" colspan="1" rowspan="1">39.23</td><td align="left" colspan="1" rowspan="1">43.63</td><td char="." align="char" colspan="1" rowspan="1">42.13</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Max</bold>
</td><td align="left" colspan="1" rowspan="1">67</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">185</td><td align="left" colspan="1" rowspan="1">135</td><td align="left" colspan="1" rowspan="1">51.1</td><td align="left" colspan="1" rowspan="1">264.29</td><td align="left" colspan="1" rowspan="1">156.25</td><td char="." align="char" colspan="1" rowspan="1">217.50</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Avg</bold>
</td><td align="left" colspan="1" rowspan="1">37.11</td><td align="left" colspan="1" rowspan="1">27.53</td><td align="left" colspan="1" rowspan="1">21.07</td><td align="left" colspan="1" rowspan="1">165.48</td><td align="left" colspan="1" rowspan="1">70.78</td><td align="left" colspan="1" rowspan="1">25.86</td><td align="left" colspan="1" rowspan="1">81.68</td><td align="left" colspan="1" rowspan="1">94.27</td><td char="." align="char" colspan="1" rowspan="1">100.74</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sd</bold>
</td><td align="left" colspan="1" rowspan="1">11.66</td><td align="left" colspan="1" rowspan="1">11.58</td><td align="left" colspan="1" rowspan="1">10.89</td><td align="left" colspan="1" rowspan="1">9.29</td><td align="left" colspan="1" rowspan="1">16.28</td><td align="left" colspan="1" rowspan="1">5.69</td><td align="left" colspan="1" rowspan="1">20.08</td><td align="left" colspan="1" rowspan="1">18.05</td><td char="." align="char" colspan="1" rowspan="1">29.47</td></tr><tr><td align="left" rowspan="4" colspan="1">F31.3-8</td><td align="left" colspan="1" rowspan="1">
<bold>Min</bold>
</td><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">149</td><td align="left" colspan="1" rowspan="1">37</td><td align="left" colspan="1" rowspan="1">14.8</td><td align="left" colspan="1" rowspan="1">44.29</td><td align="left" colspan="1" rowspan="1">51.45</td><td char="." align="char" colspan="1" rowspan="1">51.52</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Max</bold>
</td><td align="left" colspan="1" rowspan="1">78</td><td align="left" colspan="1" rowspan="1">67</td><td align="left" colspan="1" rowspan="1">66</td><td align="left" colspan="1" rowspan="1">185</td><td align="left" colspan="1" rowspan="1">93</td><td align="left" colspan="1" rowspan="1">33.2</td><td align="left" colspan="1" rowspan="1">130.65</td><td align="left" colspan="1" rowspan="1">134.04</td><td char="." align="char" colspan="1" rowspan="1">163.27</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Avg</bold>
</td><td align="left" colspan="1" rowspan="1">41.62</td><td align="left" colspan="1" rowspan="1">25.07</td><td align="left" colspan="1" rowspan="1">21.62</td><td align="left" colspan="1" rowspan="1">168.87</td><td align="left" colspan="1" rowspan="1">69.67</td><td align="left" colspan="1" rowspan="1">24.43</td><td align="left" colspan="1" rowspan="1">79.20</td><td align="left" colspan="1" rowspan="1">91.47</td><td char="." align="char" colspan="1" rowspan="1">89.96</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sd</bold>
</td><td align="left" colspan="1" rowspan="1">15.45</td><td align="left" colspan="1" rowspan="1">13.44</td><td align="left" colspan="1" rowspan="1">12.20</td><td align="left" colspan="1" rowspan="1">9.48</td><td align="left" colspan="1" rowspan="1">13.57</td><td align="left" colspan="1" rowspan="1">4.48</td><td align="left" colspan="1" rowspan="1">17.17</td><td align="left" colspan="1" rowspan="1">18.61</td><td char="." align="char" colspan="1" rowspan="1">27.86</td></tr></tbody></table><table-wrap-foot><p> (Real_Day&#8201;=&#8201;Days on lithium treatment), (ICD10 : F31.1&#8201;=&#8201;Bipolar affective disorder, current episode manic without psychotic symptoms, F31.2&#8201;=&#8201;Bipolar affective disorder, current episode manic with psychotic symptoms, F31.3&#8201;=&#8201;Bipolar affective disorder, current episode mild or moderate depression, F31.4&#8201;=&#8201;Bipolar affective disorder, current episode severe depression without psychotic symptoms, F31.5&#8201;=&#8201;Bipolar affective disorder, current episode severe depression with psychotic symptoms, F31.6&#8201;=&#8201;Bipolar affective disorder, current episode mixed, F31.7&#8201;=&#8201;Bipolar affective disorder, currently in remission, F31.8&#8201;=&#8201;Other bipolar affective disorders, F31.9&#8201;=&#8201;Bipolar affective disorder, unspecified)</p></table-wrap-foot></table-wrap>
</p><p id="Par25">The most frequent comorbidities identified were thyroid abnormalities (41 patients, 5.9%), diabetes mellitus (39 patients, 5.6%), hypertension (27 patients, 3.9%), cardiovascular diseases (12 patients, 1.7%), dyslipidemia (11 patients, 1.6%), neurological disorders (8 patients, 1.1%), liver disease (5 patients, 0.7%), cancer (2 patients, 0.3%), gynecological disorders (2 patients, 0.3%), and kidney disease (1 patient, 0.1%) (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>).</p><p id="Par26">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Patient characteristics - nominal and present or absent values.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Title</th><th align="left" colspan="1" rowspan="1">Values</th><th align="left" colspan="1" rowspan="1">Tot</th><th align="left" colspan="1" rowspan="1">M</th><th align="left" colspan="1" rowspan="1">F</th><th align="left" colspan="1" rowspan="1">F31.1</th><th align="left" colspan="1" rowspan="1">F31.2</th><th align="left" colspan="1" rowspan="1">F31.9</th><th align="left" colspan="1" rowspan="1">F31.3-8</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">First episode</td><td align="left" colspan="1" rowspan="1">Mania</td><td char="." align="char" colspan="1" rowspan="1">252</td><td char="." align="char" colspan="1" rowspan="1">144</td><td char="." align="char" colspan="1" rowspan="1">108</td><td char="." align="char" colspan="1" rowspan="1">64</td><td char="." align="char" colspan="1" rowspan="1">53</td><td char="." align="char" colspan="1" rowspan="1">127</td><td char="." align="char" colspan="1" rowspan="1">8</td></tr><tr><td align="left" colspan="1" rowspan="1">Dep</td><td char="." align="char" colspan="1" rowspan="1">99</td><td char="." align="char" colspan="1" rowspan="1">44</td><td char="." align="char" colspan="1" rowspan="1">55</td><td char="." align="char" colspan="1" rowspan="1">22</td><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">52</td><td char="." align="char" colspan="1" rowspan="1">6</td></tr><tr><td align="left" colspan="1" rowspan="1">None</td><td char="." align="char" colspan="1" rowspan="1">350</td><td char="." align="char" colspan="1" rowspan="1">183</td><td char="." align="char" colspan="1" rowspan="1">165</td><td char="." align="char" colspan="1" rowspan="1">67</td><td char="." align="char" colspan="1" rowspan="1">80</td><td char="." align="char" colspan="1" rowspan="1">173</td><td char="." align="char" colspan="1" rowspan="1">28</td></tr><tr><td align="left" rowspan="5" colspan="1">Marriage</td><td align="left" colspan="1" rowspan="1">M</td><td char="." align="char" colspan="1" rowspan="1">361</td><td char="." align="char" colspan="1" rowspan="1">203</td><td char="." align="char" colspan="1" rowspan="1">158</td><td char="." align="char" colspan="1" rowspan="1">83</td><td char="." align="char" colspan="1" rowspan="1">80</td><td char="." align="char" colspan="1" rowspan="1">178</td><td char="." align="char" colspan="1" rowspan="1">20</td></tr><tr><td align="left" colspan="1" rowspan="1">S</td><td char="." align="char" colspan="1" rowspan="1">225</td><td char="." align="char" colspan="1" rowspan="1">121</td><td char="." align="char" colspan="1" rowspan="1">104</td><td char="." align="char" colspan="1" rowspan="1">51</td><td char="." align="char" colspan="1" rowspan="1">44</td><td char="." align="char" colspan="1" rowspan="1">115</td><td char="." align="char" colspan="1" rowspan="1">15</td></tr><tr><td align="left" colspan="1" rowspan="1">W</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">D</td><td char="." align="char" colspan="1" rowspan="1">76</td><td char="." align="char" colspan="1" rowspan="1">34</td><td char="." align="char" colspan="1" rowspan="1">42</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">20</td><td char="." align="char" colspan="1" rowspan="1">40</td><td char="." align="char" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">None</td><td char="." align="char" colspan="1" rowspan="1">22</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr><tr><td align="left" rowspan="4" colspan="1">Addiction</td><td align="left" colspan="1" rowspan="1">Me</td><td char="." align="char" colspan="1" rowspan="1">82</td><td char="." align="char" colspan="1" rowspan="1">60</td><td char="." align="char" colspan="1" rowspan="1">22</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">23</td><td char="." align="char" colspan="1" rowspan="1">32</td><td char="." align="char" colspan="1" rowspan="1">9</td></tr><tr><td align="left" colspan="1" rowspan="1">Am</td><td char="." align="char" colspan="1" rowspan="1">15</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">P</td><td char="." align="char" colspan="1" rowspan="1">38</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">N</td><td char="." align="char" colspan="1" rowspan="1">566</td><td char="." align="char" colspan="1" rowspan="1">276</td><td char="." align="char" colspan="1" rowspan="1">290</td><td char="." align="char" colspan="1" rowspan="1">127</td><td char="." align="char" colspan="1" rowspan="1">110</td><td char="." align="char" colspan="1" rowspan="1">298</td><td char="." align="char" colspan="1" rowspan="1">31</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Addiction</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">135</td><td char="." align="char" colspan="1" rowspan="1">96</td><td char="." align="char" colspan="1" rowspan="1">39</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">43</td><td char="." align="char" colspan="1" rowspan="1">54</td><td char="." align="char" colspan="1" rowspan="1">11</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Smoking</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">252</td><td char="." align="char" colspan="1" rowspan="1">175</td><td char="." align="char" colspan="1" rowspan="1">77</td><td char="." align="char" colspan="1" rowspan="1">58</td><td char="." align="char" colspan="1" rowspan="1">56</td><td char="." align="char" colspan="1" rowspan="1">119</td><td char="." align="char" colspan="1" rowspan="1">19</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Alcohol consumption</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">50</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">22</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">15</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="." align="char" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Suicide</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">92</td><td char="." align="char" colspan="1" rowspan="1">43</td><td char="." align="char" colspan="1" rowspan="1">49</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">53</td><td char="." align="char" colspan="1" rowspan="1">10</td></tr><tr><td align="left" colspan="1" rowspan="1">Resident city</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">422</td><td char="." align="char" colspan="1" rowspan="1">221</td><td char="." align="char" colspan="1" rowspan="1">201</td><td char="." align="char" colspan="1" rowspan="1">101</td><td char="." align="char" colspan="1" rowspan="1">87</td><td char="." align="char" colspan="1" rowspan="1">208</td><td char="." align="char" colspan="1" rowspan="1">26</td></tr><tr><td align="left" colspan="1" rowspan="1">Resident province</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">609</td><td char="." align="char" colspan="1" rowspan="1">326</td><td char="." align="char" colspan="1" rowspan="1">283</td><td char="." align="char" colspan="1" rowspan="1">136</td><td char="." align="char" colspan="1" rowspan="1">130</td><td char="." align="char" colspan="1" rowspan="1">307</td><td char="." align="char" colspan="1" rowspan="1">36</td></tr><tr><td align="left" colspan="1" rowspan="1">Iranian nationality</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">690</td><td char="." align="char" colspan="1" rowspan="1">368</td><td char="." align="char" colspan="1" rowspan="1">322</td><td char="." align="char" colspan="1" rowspan="1">152</td><td char="." align="char" colspan="1" rowspan="1">152</td><td char="." align="char" colspan="1" rowspan="1">345</td><td char="." align="char" colspan="1" rowspan="1">41</td></tr><tr><td align="left" colspan="1" rowspan="1">PPH_OCD</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">35</td><td char="." align="char" colspan="1" rowspan="1">23</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">PPH_ADHD</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">23</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">PPH_Dep</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="1" rowspan="1">PPH_PD</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">PPH_MR</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">PPH_PTSD</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Trauma &amp; head injury</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">99</td><td char="." align="char" colspan="1" rowspan="1">61</td><td char="." align="char" colspan="1" rowspan="1">38</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">20</td><td char="." align="char" colspan="1" rowspan="1">59</td><td char="." align="char" colspan="1" rowspan="1">9</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Seizure</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">81</td><td char="." align="char" colspan="1" rowspan="1">44</td><td char="." align="char" colspan="1" rowspan="1">37</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">47</td><td char="." align="char" colspan="1" rowspan="1">7</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Thyroid disorder</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">41</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Diabetes</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">39</td><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">20</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Blood pressure</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">15</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Liver disease</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_stroke</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Kidney disease</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Heart attack</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Heart disease</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_CVD</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Surgery</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Internal disease</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">24</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">H_HLP</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Neurological disease</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Women&#8217;s disease</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Urological disease</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Otolaryngology</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Cancer</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">H_Eye disease</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">F.H_bipolar disorder</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">63</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">36</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">29</td><td char="." align="char" colspan="1" rowspan="1">5</td></tr><tr><td align="left" colspan="1" rowspan="1">F.H_Mental disorder 1</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">160</td><td char="." align="char" colspan="1" rowspan="1">88</td><td char="." align="char" colspan="1" rowspan="1">72</td><td char="." align="char" colspan="1" rowspan="1">30</td><td char="." align="char" colspan="1" rowspan="1">36</td><td char="." align="char" colspan="1" rowspan="1">80</td><td char="." align="char" colspan="1" rowspan="1">14</td></tr><tr><td align="left" colspan="1" rowspan="1">F.H_Mental disorder 2</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">78</td><td char="." align="char" colspan="1" rowspan="1">40</td><td char="." align="char" colspan="1" rowspan="1">38</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="." align="char" colspan="1" rowspan="1">15</td><td char="." align="char" colspan="1" rowspan="1">41</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">F.H_Depression</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">35</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">5</td></tr><tr><td align="left" colspan="1" rowspan="1">F.H_Epilepsy</td><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr></tbody></table><table-wrap-foot><p>(H&#8201;=&#8201;History) &#8211; (F.H&#8201;=&#8201;Family History) &#8211; (PPH&#8201;=&#8201;Past psychiatric history) &#8211; (First episode; Dep&#8201;=&#8201;Depression, Mix&#8201;=&#8201;Mix episode) &#8211; (Marriage; M&#8201;=&#8201;Married, S&#8201;=&#8201;Single, D&#8201;=&#8201;Divorce, W&#8201;=&#8201;Widow) &#8211; (Addiction; Me&#8201;=&#8201;Methadone, Am&#8201;=&#8201;Amphetamine, P&#8201;=&#8201;Positive but type unknown, N&#8201;=&#8201;Negative) &#8211; (CVD&#8201;=&#8201;Cardiovascular disease) &#8211; (HLP&#8201;=&#8201;Hyperlipidemia).</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec10"><title>Patients&#8217; psychiatric characteristics</title><p id="Par27">The initial presentation of the disease was mania in 253 patients (71.8%) of the 351 patients evaluated for this criterion, while 100 patients (28.2%) initially presented with depression. Substance addiction was documented in 135 patients (19.3%), including methadone addiction in 82 patients (60.7%), amphetamine addiction in 15 patients (11.1%), and other unspecified addictions in the remaining cases. Smoking was reported by 252 patients (36.0%), and 50 patients (7.1%) consumed alcohol. Regarding past psychiatric history (PPH), obsessive-compulsive disorder (OCD) was the most common concurrent condition, affecting 35 patients (5.0%), followed by attention-deficit hyperactivity disorder (ADHD) in 23 patients (3.3%) and post-traumatic stress disorder (PTSD) in 6 patients (0.9%). Head trauma was reported in 99 patients (14.1%), and 81 patients (11.6%) experienced at least one seizure episode. Among first-degree family members, 63 patients (9.0%) had a relative with BPD, 35 patients (5.0%) had a relative with depression, and nine patients (1.3%) had a relative with a history of epilepsy. Of all the patients included, 92 patients (13.1%) had a history of suicide attempts, and four patients (0.6%) were noted to have an intellectual disability.</p><p id="Par28">Different types of BD, as classified by ICD-10, showed significant differences in terms of sex (<italic toggle="yes">P</italic>&#8201;=&#8201;0.032) and history of head trauma (<italic toggle="yes">P</italic>&#8201;=&#8201;0.017). Other factors did not significantly differ across groups, including history of OCD (<italic toggle="yes">P</italic>&#8201;=&#8201;0.926), ADHD (<italic toggle="yes">P</italic>&#8201;=&#8201;0.592), intellectual disability (<italic toggle="yes">P</italic>&#8201;=&#8201;0.487), PTSD (<italic toggle="yes">P</italic>&#8201;=&#8201;0.695), seizure (<italic toggle="yes">P</italic>&#8201;=&#8201;0.155), thyroid abnormalities (<italic toggle="yes">P</italic>&#8201;=&#8201;0.427), diabetes mellitus (<italic toggle="yes">P</italic>&#8201;=&#8201;0.462), hypertension (<italic toggle="yes">P</italic>&#8201;=&#8201;0.922), cardiovascular disease (<italic toggle="yes">P</italic>&#8201;=&#8201;0.246), dyslipidemia (<italic toggle="yes">P</italic>&#8201;=&#8201;0.109), smoking (<italic toggle="yes">P</italic>&#8201;=&#8201;0.475), and alcohol use (<italic toggle="yes">P</italic>&#8201;=&#8201;0.419).</p></sec><sec id="Sec111"><title>Patients&#8217; characteristics during hospitalization</title><p id="Par29">The mean length of hospital stay was 27.7 days (&#177;&#8201;11.4), whereas the mean duration of hospitalization during lithium treatment was 21.7 days (&#177;&#8201;10.8). A total of 1,850 lithium serum concentrations were recorded, which the technique for serum lithium level monitoring was atomic absorption, with a mean serum lithium concentration of 0.65 mEq/L (&#177;&#8201;0.30) (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>). The most commonly requested laboratory evaluations included complete blood count (CBC) (1,386 tests), serum potassium (960 tests; mean&#8201;=&#8201;4.03 mEq/L, SD&#8201;=&#8201;0.40), serum sodium (921 tests; mean&#8201;=&#8201;137.79 mEq/L, SD&#8201;=&#8201;3.07), serum creatinine (888 tests; mean&#8201;=&#8201;0.96&#160;mg/dL, SD&#8201;=&#8201;0.17), alanine transaminase (ALT) (888 tests; mean&#8201;=&#8201;25.49 U/L, SD&#8201;=&#8201;25.68), serum urea (887 tests; mean&#8201;=&#8201;28.32&#160;mg/dL, SD&#8201;=&#8201;11.87), aspartate transaminase (AST) (875 tests; mean&#8201;=&#8201;23.35 U/L, SD&#8201;=&#8201;23.74), alkaline phosphatase (ALP) (784 tests; mean&#8201;=&#8201;183.07 U/L, SD&#8201;=&#8201;82.15), serum calcium (752 tests; mean&#8201;=&#8201;9.34 mEq/L, SD&#8201;=&#8201;0.49), and serum thyroid-stimulating hormone (TSH) (173 tests; mean&#8201;=&#8201;3.98 &#181;IU/mL, SD&#8201;=&#8201;6.38).</p><p id="Par30">
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Patients&#8217; laboratory tests.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Tests</th><th align="left" colspan="1" rowspan="1">Count</th><th align="left" colspan="1" rowspan="1">Period</th><th align="left" colspan="1" rowspan="1">Min</th><th align="left" colspan="1" rowspan="1">Max</th><th align="left" colspan="1" rowspan="1">Avg</th><th align="left" colspan="1" rowspan="1">SD</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Lithium</td><td char="." align="char" colspan="1" rowspan="1">1850</td><td char="." align="char" colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">0.65</td><td char="." align="char" colspan="1" rowspan="1">0.30</td></tr><tr><td align="left" colspan="1" rowspan="1">WBC (White Blood Cells)</td><td char="." align="char" colspan="1" rowspan="1">1386</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">2.1</td><td align="left" colspan="1" rowspan="1">19.7</td><td char="." align="char" colspan="1" rowspan="1">7.73</td><td char="." align="char" colspan="1" rowspan="1">2.59</td></tr><tr><td align="left" colspan="1" rowspan="1">RBC (Red Blood Cells)</td><td char="." align="char" colspan="1" rowspan="1">1386</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">6.7</td><td char="." align="char" colspan="1" rowspan="1">4.54</td><td char="." align="char" colspan="1" rowspan="1">0.56</td></tr><tr><td align="left" colspan="1" rowspan="1">Hct (Hematocrit)</td><td char="." align="char" colspan="1" rowspan="1">1386</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">24.4</td><td align="left" colspan="1" rowspan="1">53.6</td><td char="." align="char" colspan="1" rowspan="1">39.78</td><td char="." align="char" colspan="1" rowspan="1">4.26</td></tr><tr><td align="left" colspan="1" rowspan="1">MCH (Mean Corpuscular Hemoglobin)</td><td char="." align="char" colspan="1" rowspan="1">1386</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">15.1</td><td align="left" colspan="1" rowspan="1">43.5</td><td char="." align="char" colspan="1" rowspan="1">29.43</td><td char="." align="char" colspan="1" rowspan="1">2.86</td></tr><tr><td align="left" colspan="1" rowspan="1">MCV (Mean Corposcular Volume)</td><td char="." align="char" colspan="1" rowspan="1">1386</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">55.8</td><td align="left" colspan="1" rowspan="1">122.3</td><td char="." align="char" colspan="1" rowspan="1">88.19</td><td char="." align="char" colspan="1" rowspan="1">6.94</td></tr><tr><td align="left" colspan="1" rowspan="1">MCHC (Mean Corpuscular Hemoglobin Concentration)</td><td char="." align="char" colspan="1" rowspan="1">1386</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">23.9</td><td align="left" colspan="1" rowspan="1">39.3</td><td char="." align="char" colspan="1" rowspan="1">33.34</td><td char="." align="char" colspan="1" rowspan="1">1.59</td></tr><tr><td align="left" colspan="1" rowspan="1">PMN (Polymorphonuclear neutrophils)</td><td char="." align="char" colspan="1" rowspan="1">1386</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">33</td><td align="left" colspan="1" rowspan="1">89</td><td char="." align="char" colspan="1" rowspan="1">64.14</td><td char="." align="char" colspan="1" rowspan="1">9.93</td></tr><tr><td align="left" colspan="1" rowspan="1">Hb (Hemoglobin)</td><td char="." align="char" colspan="1" rowspan="1">1385</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">5.9</td><td align="left" colspan="1" rowspan="1">19.6</td><td char="." align="char" colspan="1" rowspan="1">13.28</td><td char="." align="char" colspan="1" rowspan="1">1.72</td></tr><tr><td align="left" colspan="1" rowspan="1">Lymph (lymphocytes)</td><td char="." align="char" colspan="1" rowspan="1">1385</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">63</td><td char="." align="char" colspan="1" rowspan="1">27.98</td><td char="." align="char" colspan="1" rowspan="1">9.32</td></tr><tr><td align="left" colspan="1" rowspan="1">Mono (Mononucleosis)</td><td char="." align="char" colspan="1" rowspan="1">1383</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">4.25</td><td char="." align="char" colspan="1" rowspan="1">1.71</td></tr><tr><td align="left" colspan="1" rowspan="1">PLT (Platelet)</td><td char="." align="char" colspan="1" rowspan="1">1375</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">72</td><td align="left" colspan="1" rowspan="1">467</td><td char="." align="char" colspan="1" rowspan="1">218.23</td><td char="." align="char" colspan="1" rowspan="1">68.30</td></tr><tr><td align="left" colspan="1" rowspan="1">EOS (Eosinophil)</td><td char="." align="char" colspan="1" rowspan="1">1374</td><td char="." align="char" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">3.65</td><td char="." align="char" colspan="1" rowspan="1">1.55</td></tr><tr><td align="left" colspan="1" rowspan="1">K (Potasium)</td><td char="." align="char" colspan="1" rowspan="1">960</td><td char="." align="char" colspan="1" rowspan="1">26</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">5.5</td><td char="." align="char" colspan="1" rowspan="1">4.03</td><td char="." align="char" colspan="1" rowspan="1">0.40</td></tr><tr><td align="left" colspan="1" rowspan="1">Na (Sodium)</td><td char="." align="char" colspan="1" rowspan="1">921</td><td char="." align="char" colspan="1" rowspan="1">27</td><td align="left" colspan="1" rowspan="1">122</td><td align="left" colspan="1" rowspan="1">149</td><td char="." align="char" colspan="1" rowspan="1">137.79</td><td char="." align="char" colspan="1" rowspan="1">3.07</td></tr><tr><td align="left" colspan="1" rowspan="1">Creatinine</td><td char="." align="char" colspan="1" rowspan="1">888</td><td char="." align="char" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">0.4</td><td align="left" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0.96</td><td char="." align="char" colspan="1" rowspan="1">0.17</td></tr><tr><td align="left" colspan="1" rowspan="1">ALT or SGPT (Alanine aminotransferase)</td><td char="." align="char" colspan="1" rowspan="1">888</td><td char="." align="char" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">231</td><td char="." align="char" colspan="1" rowspan="1">25.49</td><td char="." align="char" colspan="1" rowspan="1">25.68</td></tr><tr><td align="left" colspan="1" rowspan="1">Urea</td><td char="." align="char" colspan="1" rowspan="1">887</td><td char="." align="char" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">97</td><td char="." align="char" colspan="1" rowspan="1">28.32</td><td char="." align="char" colspan="1" rowspan="1">11.87</td></tr><tr><td align="left" colspan="1" rowspan="1">AST or SGOT (aspartate aminotransferase)</td><td char="." align="char" colspan="1" rowspan="1">875</td><td char="." align="char" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">402</td><td char="." align="char" colspan="1" rowspan="1">25.35</td><td char="." align="char" colspan="1" rowspan="1">23.74</td></tr><tr><td align="left" colspan="1" rowspan="1">ALP (Alkaline phosphatase)</td><td char="." align="char" colspan="1" rowspan="1">784</td><td char="." align="char" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">52</td><td align="left" colspan="1" rowspan="1">1199</td><td char="." align="char" colspan="1" rowspan="1">183.07</td><td char="." align="char" colspan="1" rowspan="1">82.15</td></tr><tr><td align="left" colspan="1" rowspan="1">Ca (Calcium)</td><td char="." align="char" colspan="1" rowspan="1">752</td><td char="." align="char" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">7.7</td><td align="left" colspan="1" rowspan="1">10.8</td><td char="." align="char" colspan="1" rowspan="1">9.34</td><td char="." align="char" colspan="1" rowspan="1">0.49</td></tr><tr><td align="left" colspan="1" rowspan="1">TSH (Thyroid stimulating hormone)</td><td char="." align="char" colspan="1" rowspan="1">173</td><td char="." align="char" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">0.1</td><td align="left" colspan="1" rowspan="1">50.9</td><td char="." align="char" colspan="1" rowspan="1">3.98</td><td char="." align="char" colspan="1" rowspan="1">6.38</td></tr><tr><td align="left" colspan="1" rowspan="1">RDW-CV (Red blood cell distribution width)</td><td char="." align="char" colspan="1" rowspan="1">113</td><td char="." align="char" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">11.8</td><td align="left" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">13.90</td><td char="." align="char" colspan="1" rowspan="1">1.48</td></tr><tr><td align="left" colspan="1" rowspan="1">Fe (Iron)</td><td char="." align="char" colspan="1" rowspan="1">49</td><td char="." align="char" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">18</td><td align="left" colspan="1" rowspan="1">156</td><td char="." align="char" colspan="1" rowspan="1">79.14</td><td char="." align="char" colspan="1" rowspan="1">32.71</td></tr><tr><td align="left" colspan="1" rowspan="1">TIBC (Total iron binding capacity)</td><td char="." align="char" colspan="1" rowspan="1">46</td><td char="." align="char" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">257</td><td align="left" colspan="1" rowspan="1">708</td><td char="." align="char" colspan="1" rowspan="1">374.28</td><td char="." align="char" colspan="1" rowspan="1">80.50</td></tr><tr><td align="left" colspan="1" rowspan="1">Folic Acid</td><td char="." align="char" colspan="1" rowspan="1">45</td><td char="." align="char" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">2.1</td><td align="left" colspan="1" rowspan="1">120.8</td><td char="." align="char" colspan="1" rowspan="1">15.72</td><td char="." align="char" colspan="1" rowspan="1">18.58</td></tr><tr><td align="left" colspan="1" rowspan="1">MGS (Serum Magnesium)</td><td char="." align="char" colspan="1" rowspan="1">23</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.9</td><td align="left" colspan="1" rowspan="1">2.6</td><td char="." align="char" colspan="1" rowspan="1">2.17</td><td char="." align="char" colspan="1" rowspan="1">0.19</td></tr><tr><td align="left" colspan="1" rowspan="1">Albumin</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">3.5</td><td align="left" colspan="1" rowspan="1">4.8</td><td char="." align="char" colspan="1" rowspan="1">4.20</td><td char="." align="char" colspan="1" rowspan="1">0.43</td></tr></tbody></table></table-wrap>
</p><p id="Par31">It is important to note that, based on the doctor&#8217;s prescription, each test may be repeated multiple times throughout the patient&#8217;s treatment period. For the serum lithium concentration test, the highest number of repetitions recorded for an individual was 12 instances. For other tests, the most frequent repetitions were observed for serum sodium (27 instances), serum potassium (26 instances), and CBC tests (20 instances). Detailed information about the frequency of each test is provided in Table&#160;<xref rid="Tab4" ref-type="table">4</xref>. For all tests, the minimum number of prescriptions was one.</p><p id="Par32">The average lithium dose prescribed was 41.05&#8201;&#215;&#8201;300&#160;mg (&#177;&#8201;30.14) (Table&#160;<xref rid="Tab5" ref-type="table">5</xref>). The most prevalent drug concurrently prescribed with lithium was sodium valproate (<italic toggle="yes">n</italic>&#8201;=&#8201;553; mean&#8201;=&#8201;68.69&#8201;&#215;&#8201;200&#160;mg, SD&#8201;=&#8201;61.34), followed by lorazepam (<italic toggle="yes">n</italic>&#8201;=&#8201;468; mean&#8201;=&#8201;28.15&#8201;&#215;&#8201;1&#160;mg, SD&#8201;=&#8201;24.09), risperidone (<italic toggle="yes">n</italic>&#8201;=&#8201;458; mean&#8201;=&#8201;65.75&#8201;&#215;&#8201;1&#160;mg, SD&#8201;=&#8201;57.13), haloperidol (<italic toggle="yes">n</italic>&#8201;=&#8201;366; mean&#8201;=&#8201;4.30&#8201;&#215;&#8201;5&#160;mg, SD&#8201;=&#8201;5.47), quetiapine (<italic toggle="yes">n</italic>&#8201;=&#8201;297; mean&#8201;=&#8201;97.28&#8201;&#215;&#8201;25&#160;mg, SD&#8201;=&#8201;114.09), biperiden (<italic toggle="yes">n</italic>&#8201;=&#8201;294; mean&#8201;=&#8201;19.35&#8201;&#215;&#8201;2&#160;mg, SD&#8201;=&#8201;20.05), midazolam (<italic toggle="yes">n</italic>&#8201;=&#8201;294; mean&#8201;=&#8201;3.00&#8201;&#215;&#8201;5&#160;mg/ml, SD&#8201;=&#8201;3.14), clonazepam (<italic toggle="yes">n</italic>&#8201;=&#8201;241; mean&#8201;=&#8201;22.28&#8201;&#215;&#8201;1&#160;mg, SD&#8201;=&#8201;23.91), olanzapine (<italic toggle="yes">n</italic>&#8201;=&#8201;207; mean&#8201;=&#8201;34.49&#8201;&#215;&#8201;5&#160;mg, SD&#8201;=&#8201;35.07), gabapentin (<italic toggle="yes">n</italic>&#8201;=&#8201;205; mean&#8201;=&#8201;49.34&#8201;&#215;&#8201;100&#160;mg, SD&#8201;=&#8201;62.84), naproxen (<italic toggle="yes">n</italic>&#8201;=&#8201;200; mean&#8201;=&#8201;28.29&#8201;&#215;&#8201;250&#160;mg, SD&#8201;=&#8201;33.23), promethazine (<italic toggle="yes">n</italic>&#8201;=&#8201;196; mean&#8201;=&#8201;3.41&#8201;&#215;&#8201;50&#160;mg/ml, SD&#8201;=&#8201;3.95), propranolol (<italic toggle="yes">n</italic>&#8201;=&#8201;141; mean&#8201;=&#8201;36.54&#8201;&#215;&#8201;10&#160;mg, SD&#8201;=&#8201;35.31), clozapine (<italic toggle="yes">n</italic>&#8201;=&#8201;109; mean&#8201;=&#8201;54.94&#8201;&#215;&#8201;25&#160;mg, SD&#8201;=&#8201;70.94), and aripiprazole (<italic toggle="yes">n</italic>&#8201;=&#8201;106; mean&#8201;=&#8201;41.80&#8201;&#215;&#8201;5&#160;mg, SD&#8201;=&#8201;45.61).</p><p id="Par36">
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Medications taken by patients.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Drugs</th><th align="left" colspan="7" rowspan="1">Persons</th><th align="left" colspan="3" rowspan="1">Dose(<italic toggle="yes">n</italic>)</th></tr><tr><th align="left" colspan="1" rowspan="1">Tot</th><th align="left" colspan="1" rowspan="1">M</th><th align="left" colspan="1" rowspan="1">F</th><th align="left" colspan="1" rowspan="1">F31.1</th><th align="left" colspan="1" rowspan="1">F31.2</th><th align="left" colspan="1" rowspan="1">F31.9</th><th align="left" colspan="1" rowspan="1">F31.3-8</th><th align="left" colspan="1" rowspan="1">Quantity</th><th align="left" colspan="1" rowspan="1">Avg</th><th align="left" colspan="1" rowspan="1">SD</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Lithium 300 (mg)</td><td char="." align="char" colspan="1" rowspan="1">701</td><td char="." align="char" colspan="1" rowspan="1">372</td><td char="." align="char" colspan="1" rowspan="1">329</td><td char="." align="char" colspan="1" rowspan="1">154</td><td char="." align="char" colspan="1" rowspan="1">153</td><td char="." align="char" colspan="1" rowspan="1">352</td><td char="." align="char" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">28,775</td><td char="." align="char" colspan="1" rowspan="1">41.05</td><td char="." align="char" colspan="1" rowspan="1">30.14</td></tr><tr><td align="left" colspan="1" rowspan="1">Valproate 200.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">553</td><td char="." align="char" colspan="1" rowspan="1">304</td><td char="." align="char" colspan="1" rowspan="1">249</td><td char="." align="char" colspan="1" rowspan="1">124</td><td char="." align="char" colspan="1" rowspan="1">121</td><td char="." align="char" colspan="1" rowspan="1">280</td><td char="." align="char" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1">37987.2</td><td char="." align="char" colspan="1" rowspan="1">68.69</td><td char="." align="char" colspan="1" rowspan="1">61.34</td></tr><tr><td align="left" colspan="1" rowspan="1">Lorazepam 1.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">468</td><td char="." align="char" colspan="1" rowspan="1">238</td><td char="." align="char" colspan="1" rowspan="1">230</td><td char="." align="char" colspan="1" rowspan="1">102</td><td char="." align="char" colspan="1" rowspan="1">104</td><td char="." align="char" colspan="1" rowspan="1">240</td><td char="." align="char" colspan="1" rowspan="1">22</td><td align="left" colspan="1" rowspan="1">13,174</td><td char="." align="char" colspan="1" rowspan="1">28.15</td><td char="." align="char" colspan="1" rowspan="1">24.09</td></tr><tr><td align="left" colspan="1" rowspan="1">Risperidone 1.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">458</td><td char="." align="char" colspan="1" rowspan="1">257</td><td char="." align="char" colspan="1" rowspan="1">201</td><td char="." align="char" colspan="1" rowspan="1">95</td><td char="." align="char" colspan="1" rowspan="1">102</td><td char="." align="char" colspan="1" rowspan="1">240</td><td char="." align="char" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1">30112.6</td><td char="." align="char" colspan="1" rowspan="1">65.75</td><td char="." align="char" colspan="1" rowspan="1">57.13</td></tr><tr><td align="left" colspan="1" rowspan="1">Haloperidol 5.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">366</td><td char="." align="char" colspan="1" rowspan="1">207</td><td char="." align="char" colspan="1" rowspan="1">159</td><td char="." align="char" colspan="1" rowspan="1">74</td><td char="." align="char" colspan="1" rowspan="1">83</td><td char="." align="char" colspan="1" rowspan="1">190</td><td char="." align="char" colspan="1" rowspan="1">19</td><td align="left" colspan="1" rowspan="1">1572</td><td char="." align="char" colspan="1" rowspan="1">4.30</td><td char="." align="char" colspan="1" rowspan="1">5.47</td></tr><tr><td align="left" colspan="1" rowspan="1">Divalproex 250.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">315</td><td char="." align="char" colspan="1" rowspan="1">145</td><td char="." align="char" colspan="1" rowspan="1">170</td><td char="." align="char" colspan="1" rowspan="1">69</td><td char="." align="char" colspan="1" rowspan="1">67</td><td char="." align="char" colspan="1" rowspan="1">165</td><td char="." align="char" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">8433</td><td char="." align="char" colspan="1" rowspan="1">26.77</td><td char="." align="char" colspan="1" rowspan="1">34.14</td></tr><tr><td align="left" colspan="1" rowspan="1">Quetiapine 25.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">297</td><td char="." align="char" colspan="1" rowspan="1">162</td><td char="." align="char" colspan="1" rowspan="1">135</td><td char="." align="char" colspan="1" rowspan="1">58</td><td char="." align="char" colspan="1" rowspan="1">61</td><td char="." align="char" colspan="1" rowspan="1">156</td><td char="." align="char" colspan="1" rowspan="1">22</td><td align="left" colspan="1" rowspan="1">28,893</td><td char="." align="char" colspan="1" rowspan="1">97.28</td><td char="." align="char" colspan="1" rowspan="1">114.09</td></tr><tr><td align="left" colspan="1" rowspan="1">Biperiden 2.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">294</td><td char="." align="char" colspan="1" rowspan="1">174</td><td char="." align="char" colspan="1" rowspan="1">120</td><td char="." align="char" colspan="1" rowspan="1">58</td><td char="." align="char" colspan="1" rowspan="1">63</td><td char="." align="char" colspan="1" rowspan="1">160</td><td char="." align="char" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">5690</td><td char="." align="char" colspan="1" rowspan="1">19.35</td><td char="." align="char" colspan="1" rowspan="1">20.05</td></tr><tr><td align="left" colspan="1" rowspan="1">Midazolam 5.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">294</td><td char="." align="char" colspan="1" rowspan="1">163</td><td char="." align="char" colspan="1" rowspan="1">131</td><td char="." align="char" colspan="1" rowspan="1">68</td><td char="." align="char" colspan="1" rowspan="1">67</td><td char="." align="char" colspan="1" rowspan="1">142</td><td char="." align="char" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">883</td><td char="." align="char" colspan="1" rowspan="1">3.00</td><td char="." align="char" colspan="1" rowspan="1">3.14</td></tr><tr><td align="left" colspan="1" rowspan="1">Clonazepam 1.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">241</td><td char="." align="char" colspan="1" rowspan="1">154</td><td char="." align="char" colspan="1" rowspan="1">87</td><td char="." align="char" colspan="1" rowspan="1">41</td><td char="." align="char" colspan="1" rowspan="1">51</td><td char="." align="char" colspan="1" rowspan="1">125</td><td char="." align="char" colspan="1" rowspan="1">24</td><td align="left" colspan="1" rowspan="1">5369.8</td><td char="." align="char" colspan="1" rowspan="1">22.28</td><td char="." align="char" colspan="1" rowspan="1">23.91</td></tr><tr><td align="left" colspan="1" rowspan="1">Olanzapine 5.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">207</td><td char="." align="char" colspan="1" rowspan="1">110</td><td char="." align="char" colspan="1" rowspan="1">97</td><td char="." align="char" colspan="1" rowspan="1">45</td><td char="." align="char" colspan="1" rowspan="1">49</td><td char="." align="char" colspan="1" rowspan="1">101</td><td char="." align="char" colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1">7140.1</td><td char="." align="char" colspan="1" rowspan="1">34.49</td><td char="." align="char" colspan="1" rowspan="1">35.07</td></tr><tr><td align="left" colspan="1" rowspan="1">Gabapentin 100.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">205</td><td char="." align="char" colspan="1" rowspan="1">146</td><td char="." align="char" colspan="1" rowspan="1">59</td><td char="." align="char" colspan="1" rowspan="1">34</td><td char="." align="char" colspan="1" rowspan="1">53</td><td char="." align="char" colspan="1" rowspan="1">103</td><td char="." align="char" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">10,115</td><td char="." align="char" colspan="1" rowspan="1">49.34</td><td char="." align="char" colspan="1" rowspan="1">62.84</td></tr><tr><td align="left" colspan="1" rowspan="1">Naproxen 250.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">200</td><td char="." align="char" colspan="1" rowspan="1">125</td><td char="." align="char" colspan="1" rowspan="1">75</td><td char="." align="char" colspan="1" rowspan="1">40</td><td char="." align="char" colspan="1" rowspan="1">54</td><td char="." align="char" colspan="1" rowspan="1">92</td><td char="." align="char" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">5658</td><td char="." align="char" colspan="1" rowspan="1">28.29</td><td char="." align="char" colspan="1" rowspan="1">33.23</td></tr><tr><td align="left" colspan="1" rowspan="1">Promethazine 50.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">196</td><td char="." align="char" colspan="1" rowspan="1">108</td><td char="." align="char" colspan="1" rowspan="1">88</td><td char="." align="char" colspan="1" rowspan="1">47</td><td char="." align="char" colspan="1" rowspan="1">40</td><td char="." align="char" colspan="1" rowspan="1">104</td><td char="." align="char" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">668.6</td><td char="." align="char" colspan="1" rowspan="1">3.41</td><td char="." align="char" colspan="1" rowspan="1">3.95</td></tr><tr><td align="left" colspan="1" rowspan="1">Propranolol 10.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">141</td><td char="." align="char" colspan="1" rowspan="1">71</td><td char="." align="char" colspan="1" rowspan="1">70</td><td char="." align="char" colspan="1" rowspan="1">36</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1">66</td><td char="." align="char" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">5152</td><td char="." align="char" colspan="1" rowspan="1">36.54</td><td char="." align="char" colspan="1" rowspan="1">35.31</td></tr><tr><td align="left" colspan="1" rowspan="1">Clozapine 25.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">109</td><td char="." align="char" colspan="1" rowspan="1">81</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">22</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1">54</td><td char="." align="char" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">5988</td><td char="." align="char" colspan="1" rowspan="1">54.94</td><td char="." align="char" colspan="1" rowspan="1">70.94</td></tr><tr><td align="left" colspan="1" rowspan="1">Aripiprazole 5.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">106</td><td char="." align="char" colspan="1" rowspan="1">39</td><td char="." align="char" colspan="1" rowspan="1">67</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1">24</td><td char="." align="char" colspan="1" rowspan="1">47</td><td char="." align="char" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">4431</td><td char="." align="char" colspan="1" rowspan="1">41.80</td><td char="." align="char" colspan="1" rowspan="1">45.61</td></tr><tr><td align="left" colspan="1" rowspan="1">Clonidine 0.2 (mg)</td><td char="." align="char" colspan="1" rowspan="1">86</td><td char="." align="char" colspan="1" rowspan="1">64</td><td char="." align="char" colspan="1" rowspan="1">22</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1">38</td><td char="." align="char" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">507.1</td><td char="." align="char" colspan="1" rowspan="1">5.90</td><td char="." align="char" colspan="1" rowspan="1">5.80</td></tr><tr><td align="left" colspan="1" rowspan="1">Folate 0.4 (mg)</td><td char="." align="char" colspan="1" rowspan="1">86</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">58</td><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1">38</td><td char="." align="char" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">5058.5</td><td char="." align="char" colspan="1" rowspan="1">58.82</td><td char="." align="char" colspan="1" rowspan="1">77.57</td></tr><tr><td align="left" colspan="1" rowspan="1">Bismuth 120.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">74</td><td char="." align="char" colspan="1" rowspan="1">49</td><td char="." align="char" colspan="1" rowspan="1">25</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">39</td><td char="." align="char" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">506</td><td char="." align="char" colspan="1" rowspan="1">6.84</td><td char="." align="char" colspan="1" rowspan="1">8.74</td></tr><tr><td align="left" colspan="1" rowspan="1">Metformin 500.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">72</td><td char="." align="char" colspan="1" rowspan="1">34</td><td char="." align="char" colspan="1" rowspan="1">38</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">30</td><td char="." align="char" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">2157</td><td char="." align="char" colspan="1" rowspan="1">29.96</td><td char="." align="char" colspan="1" rowspan="1">32.83</td></tr><tr><td align="left" colspan="1" rowspan="1">Atorvastatin 20.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">70</td><td char="." align="char" colspan="1" rowspan="1">36</td><td char="." align="char" colspan="1" rowspan="1">34</td><td char="." align="char" colspan="1" rowspan="1">24</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">29</td><td char="." align="char" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">1255</td><td char="." align="char" colspan="1" rowspan="1">17.93</td><td char="." align="char" colspan="1" rowspan="1">12.64</td></tr><tr><td align="left" colspan="1" rowspan="1">Methadone 5 (mg)</td><td char="." align="char" colspan="1" rowspan="1">60</td><td char="." align="char" colspan="1" rowspan="1">48</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">29</td><td char="." align="char" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">3826</td><td char="." align="char" colspan="1" rowspan="1">63.77</td><td char="." align="char" colspan="1" rowspan="1">76.95</td></tr><tr><td align="left" colspan="1" rowspan="1">Fluphenazine 25.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">57</td><td char="." align="char" colspan="1" rowspan="1">39</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">39</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">75</td><td char="." align="char" colspan="1" rowspan="1">1.32</td><td char="." align="char" colspan="1" rowspan="1">0.60</td></tr><tr><td align="left" colspan="1" rowspan="1">Cyproterone 50 (mg)</td><td char="." align="char" colspan="1" rowspan="1">51</td><td char="." align="char" colspan="1" rowspan="1">24</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">748</td><td char="." align="char" colspan="1" rowspan="1">14.67</td><td char="." align="char" colspan="1" rowspan="1">13.69</td></tr><tr><td align="left" colspan="1" rowspan="1">Sertraline 50.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">49</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">22</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">25</td><td char="." align="char" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">743</td><td char="." align="char" colspan="1" rowspan="1">15.16</td><td char="." align="char" colspan="1" rowspan="1">20.73</td></tr><tr><td align="left" colspan="1" rowspan="1">Carbamazepine 200.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">45</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">22</td><td char="." align="char" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">1354</td><td char="." align="char" colspan="1" rowspan="1">30.09</td><td char="." align="char" colspan="1" rowspan="1">35.02</td></tr><tr><td align="left" colspan="1" rowspan="1">Omeprazole 20.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">45</td><td char="." align="char" colspan="1" rowspan="1">20</td><td char="." align="char" colspan="1" rowspan="1">25</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">610</td><td char="." align="char" colspan="1" rowspan="1">13.56</td><td char="." align="char" colspan="1" rowspan="1">11.30</td></tr><tr><td align="left" colspan="1" rowspan="1">Haloperidol 0.5 (mg)</td><td char="." align="char" colspan="1" rowspan="1">44</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">549</td><td char="." align="char" colspan="1" rowspan="1">12.48</td><td char="." align="char" colspan="1" rowspan="1">15.19</td></tr><tr><td align="left" colspan="1" rowspan="1">Lamotrigine 25.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">43</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">2118</td><td char="." align="char" colspan="1" rowspan="1">49.26</td><td char="." align="char" colspan="1" rowspan="1">81.02</td></tr><tr><td align="left" colspan="1" rowspan="1">Zolpidem 5.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">43</td><td char="." align="char" colspan="1" rowspan="1">38</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">30</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">225</td><td char="." align="char" colspan="1" rowspan="1">5.23</td><td char="." align="char" colspan="1" rowspan="1">4.38</td></tr><tr><td align="left" colspan="1" rowspan="1">Fluconazole 150.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">42</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">40</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">122</td><td char="." align="char" colspan="1" rowspan="1">2.90</td><td char="." align="char" colspan="1" rowspan="1">1.76</td></tr><tr><td align="left" colspan="1" rowspan="1">Flupentixol 20.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">42</td><td char="." align="char" colspan="1" rowspan="1">27</td><td char="." align="char" colspan="1" rowspan="1">15</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">32</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">54</td><td char="." align="char" colspan="1" rowspan="1">1.29</td><td char="." align="char" colspan="1" rowspan="1">0.45</td></tr><tr><td align="left" colspan="1" rowspan="1">Pantoprazole 20.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">41</td><td char="." align="char" colspan="1" rowspan="1">24</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">20</td><td char="." align="char" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">654</td><td char="." align="char" colspan="1" rowspan="1">15.95</td><td char="." align="char" colspan="1" rowspan="1">16.43</td></tr><tr><td align="left" colspan="1" rowspan="1">Azithromycin 250.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">37</td><td char="." align="char" colspan="1" rowspan="1">26</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">211</td><td char="." align="char" colspan="1" rowspan="1">5.70</td><td char="." align="char" colspan="1" rowspan="1">6.40</td></tr><tr><td align="left" colspan="1" rowspan="1">Cefalexin 500.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">35</td><td char="." align="char" colspan="1" rowspan="1">25</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">20</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">505</td><td char="." align="char" colspan="1" rowspan="1">14.43</td><td char="." align="char" colspan="1" rowspan="1">9.55</td></tr><tr><td align="left" colspan="1" rowspan="1">Levothyroxine 0.05 (mg)</td><td char="." align="char" colspan="1" rowspan="1">34</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">23</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">1062</td><td char="." align="char" colspan="1" rowspan="1">31.24</td><td char="." align="char" colspan="1" rowspan="1">26.01</td></tr><tr><td align="left" colspan="1" rowspan="1">Vitamin C 1000.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">34</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">113.6</td><td char="." align="char" colspan="1" rowspan="1">3.34</td><td char="." align="char" colspan="1" rowspan="1">4.68</td></tr><tr><td align="left" colspan="1" rowspan="1">Citalopram 20.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">32</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">25</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">150</td><td char="." align="char" colspan="1" rowspan="1">4.69</td><td char="." align="char" colspan="1" rowspan="1">3.95</td></tr><tr><td align="left" colspan="1" rowspan="1">Magnesium hydroxide 250 (mg)</td><td char="." align="char" colspan="1" rowspan="1">32</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">43.6</td><td char="." align="char" colspan="1" rowspan="1">1.36</td><td char="." align="char" colspan="1" rowspan="1">1.00</td></tr><tr><td align="left" colspan="1" rowspan="1">Chlorpromazine 25.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">14</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">359</td><td char="." align="char" colspan="1" rowspan="1">12.82</td><td char="." align="char" colspan="1" rowspan="1">15.81</td></tr><tr><td align="left" colspan="1" rowspan="1">Calcium-D 500(mg)-200(IU)</td><td char="." align="char" colspan="1" rowspan="1">21</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">360</td><td char="." align="char" colspan="1" rowspan="1">17.14</td><td char="." align="char" colspan="1" rowspan="1">15.60</td></tr><tr><td align="left" colspan="1" rowspan="1">Topiramate 25.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">20</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1525</td><td char="." align="char" colspan="1" rowspan="1">76.25</td><td char="." align="char" colspan="1" rowspan="1">90.79</td></tr><tr><td align="left" colspan="1" rowspan="1">Fluoxetine 10.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">345</td><td char="." align="char" colspan="1" rowspan="1">18.16</td><td char="." align="char" colspan="1" rowspan="1">33.09</td></tr><tr><td align="left" colspan="1" rowspan="1">Levetiracetam 500.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">18</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">261</td><td char="." align="char" colspan="1" rowspan="1">14.50</td><td char="." align="char" colspan="1" rowspan="1">17.92</td></tr><tr><td align="left" colspan="1" rowspan="1">Amitriptyline 10.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">17</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">307</td><td char="." align="char" colspan="1" rowspan="1">18.06</td><td char="." align="char" colspan="1" rowspan="1">22.34</td></tr><tr><td align="left" colspan="1" rowspan="1">Trihexyphenidyl 2.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">16</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">241.5</td><td char="." align="char" colspan="1" rowspan="1">15.09</td><td char="." align="char" colspan="1" rowspan="1">14.22</td></tr><tr><td align="left" colspan="1" rowspan="1">Cobalamin 1000 (&#181;g)</td><td char="." align="char" colspan="1" rowspan="1">15</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">60</td><td char="." align="char" colspan="1" rowspan="1">4.00</td><td char="." align="char" colspan="1" rowspan="1">3.93</td></tr><tr><td align="left" colspan="1" rowspan="1">Perphenazine 2.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">152</td><td char="." align="char" colspan="1" rowspan="1">11.69</td><td char="." align="char" colspan="1" rowspan="1">9.95</td></tr><tr><td align="left" colspan="1" rowspan="1">Tizanidine 4.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">13</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">97</td><td char="." align="char" colspan="1" rowspan="1">7.46</td><td char="." align="char" colspan="1" rowspan="1">5.96</td></tr><tr><td align="left" colspan="1" rowspan="1">Bupropion 75.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">86.3</td><td char="." align="char" colspan="1" rowspan="1">7.19</td><td char="." align="char" colspan="1" rowspan="1">4.59</td></tr><tr><td align="left" colspan="1" rowspan="1">Chlordiazepoxide 5.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">12</td><td char="." align="char" colspan="1" rowspan="1">11</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">80</td><td char="." align="char" colspan="1" rowspan="1">6.67</td><td char="." align="char" colspan="1" rowspan="1">7.33</td></tr><tr><td align="left" colspan="1" rowspan="1">Alprazolam 0.5 (mg)</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">42</td><td char="." align="char" colspan="1" rowspan="1">4.20</td><td char="." align="char" colspan="1" rowspan="1">4.38</td></tr><tr><td align="left" colspan="1" rowspan="1">Oxybutynin 5.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">10</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">75</td><td char="." align="char" colspan="1" rowspan="1">7.50</td><td char="." align="char" colspan="1" rowspan="1">7.80</td></tr><tr><td align="left" colspan="1" rowspan="1">Glibenclamide 5.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">9</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">44</td><td char="." align="char" colspan="1" rowspan="1">4.89</td><td char="." align="char" colspan="1" rowspan="1">4.51</td></tr><tr><td align="left" colspan="1" rowspan="1">Thiamine 100.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">8</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">215</td><td char="." align="char" colspan="1" rowspan="1">26.88</td><td char="." align="char" colspan="1" rowspan="1">30.88</td></tr><tr><td align="left" colspan="1" rowspan="1">Furosemide 40.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">84.5125</td><td char="." align="char" colspan="1" rowspan="1">12.07</td><td char="." align="char" colspan="1" rowspan="1">10.90</td></tr><tr><td align="left" colspan="1" rowspan="1">Vitamin <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="D50000">D50000</ext-link> (IU)</td><td char="." align="char" colspan="1" rowspan="1">7</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">28</td><td char="." align="char" colspan="1" rowspan="1">4.00</td><td char="." align="char" colspan="1" rowspan="1">2.98</td></tr><tr><td align="left" colspan="1" rowspan="1">Vitamin E100.0 (IU)</td><td char="." align="char" colspan="1" rowspan="1">6</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">48</td><td char="." align="char" colspan="1" rowspan="1">8.00</td><td char="." align="char" colspan="1" rowspan="1">8.39</td></tr><tr><td align="left" colspan="1" rowspan="1">Amantadine 100.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">5</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">4</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">19</td><td char="." align="char" colspan="1" rowspan="1">3.80</td><td char="." align="char" colspan="1" rowspan="1">5.11</td></tr><tr><td align="left" colspan="1" rowspan="1">Phenobarbital 60.0 (mg)</td><td char="." align="char" colspan="1" rowspan="1">3</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">1</td><td char="." align="char" colspan="1" rowspan="1">2</td><td char="." align="char" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">151.6</td><td char="." align="char" colspan="1" rowspan="1">50.53</td><td char="." align="char" colspan="1" rowspan="1">44.41</td></tr></tbody></table></table-wrap>
</p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par37">The current study represents the first of its kind conducted in Iran, specifically in Mashhad, named <italic toggle="yes">First Iranian Study Evaluating Serum Levels of Lithium in Patients for Population Pharmacokinetics (FIRELOLIPOP)</italic>. Several studies have previously been conducted in Iran, including national-level investigations<sup><xref ref-type="bibr" rid="CR45">45</xref>&#8211;<xref ref-type="bibr" rid="CR50">50</xref></sup> and local studies based specifically in Mashhad<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>. However, these studies primarily focused on other topics, such as the simultaneous analysis of risk factors and the evaluation of treatment efficacy through randomized controlled trials. The unique aspects of our study include the large sample size, the extensive range and variety of extracted features, and the meticulous approach to data filtering and organization.</p><p id="Par38">Globally, lithium is recognized as one of the most effective and widely used treatments for managing BD<sup><xref ref-type="bibr" rid="CR53">53</xref>&#8211;<xref ref-type="bibr" rid="CR55">55</xref></sup>. Its efficacy in preventing relapse has been well established<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. However, as highlighted in prior research<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>, the use of lithium is complicated by its narrow therapeutic window, the necessity of long-term use for many patients, and the need for regular monitoring of various parameters. These challenges contribute to reduced adherence and declining prescription rates. For instance, it has been reported that less than 35% of BD patients worldwide are currently treated with lithium<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. Similarly, our study found that only about 25% of bipolar patients admitted to Ibn Sina Hospital in Mashhad were treated with lithium.</p><p id="Par39">Despite these challenges, lithium remains a first-line treatment for BD<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. A key objective of this study was to establish a comprehensive database to support data science and artificial intelligence-based modeling for analyzing lithium&#8217;s treatment process and predicting its concentration-time stability.</p><p id="Par40">In line with the findings of Malhi et al.<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, which suggest that optimal maintenance concentrations lie in the lower end of the therapeutic range (0.6&#8211;0.8 mmol/L), our study found an average serum lithium concentration of 0.65 mmol/L (SD&#8201;&#177;&#8201;0.3), reinforcing current treatment guidelines.</p><p id="Par41">Diagnostic coding further supported lithium&#8217;s primary use in managing manic symptoms: 307 patients (44%) carried ICD-10 codes F31.1 and F31.2, indicating manic without or with psychotic symptoms. These results are consistent with prior research confirming lithium&#8217;s potential efficacy for acute mania<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR60">60</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>. On the other hand, lithium appears less effective in depressive episodes, as noted by other previous studies<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>, and reflected in our data&#8212;only 24 patients (under 4%) had ICD-10 codes corresponding to depressive states (F31.3&#8211;F31.5).</p><p id="Par42">Another key benefit of lithium is its anti-suicidal effect<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>, attributed in part to its neuroprotective mechanisms<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Studies show lithium substantially reduces suicide risk<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>. In our study, 92 patients (13%) had a history of suicide attempts, and 47 patients (7%) experienced suicidal thoughts. This data underscores the importance of lithium&#8217;s protective effects for this group, representing 20% of the study population. Furthermore, the remaining 80% of patients without a history of suicidal attempts or thoughts may have benefited from the positive effects of lithium.</p><p id="Par43">Another unique aspect of this study is the data collected on the concomitant use of more than 60 drugs during lithium treatment. Examining the interactions between these drugs and lithium will be a key goal for future research. For example, past studies have evaluated the combined use of lithium and valproate, finding this combination to be generally beneficial or neutral<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR63">63</xref>,<xref ref-type="bibr" rid="CR64">64</xref></sup>. In our dataset, over 80% of patients received either valproate or its derivative Divalproex<sup>&#174;</sup> in combination with lithium, making this drug family the most commonly co-prescribed with lithium. Similarly, antipsychotics such as olanzapine (<italic toggle="yes">n</italic>&#8201;=&#8201;207) and phenothiazines like perphenazine and chlorpromazine (<italic toggle="yes">n</italic>&#8201;=&#8201;40) were commonly prescribed, consistent with findings from Iranian studies<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Our data also capture vitamin supplementation patterns noted previously<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, allowing for future subgroup analyses.</p><p id="Par44">Renal function monitoring is critical in long-term lithium therapy<sup><xref ref-type="bibr" rid="CR63">63</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>. To address this, we calculated GFR using MDRD, CKD-EPI, and Cockcroft&#8211;Gault formulas, providing a multi-faceted view of kidney function that will inform future pharmacokinetic models.</p><p id="Par45">Genetic factors play an essential role in bipolar disorder, as shown in several studies<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR53">53</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>. Although genetic sequencing data is not available in our study, the recorded family history of bipolar disorder and depression provides a valuable proxy for exploring genetic and familial influences. Notably, 283 patients (40%) had a first- or second-degree relative with bipolar disorder, depression, or another psychiatric condition&#8212;highlighting the relevance of familial factors in this population. Neuroimaging and biomarker studies<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR60">60</xref></sup> have provided valuable insight into lithium&#8217;s effects on brain function, though such data were not available here. Nonetheless, emerging tools such as machine learning<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> may offer less invasive alternatives, facilitating early diagnosis and treatment optimization while improving patient comfort and reducing costs.</p><p id="Par46">Lithium&#8217;s narrow therapeutic window remains its main limitation. Pharmacokinetic-based modeling offers a promising solution to address this challenge. The goal of pharmacokinetics is to study the time course of drug and metabolite concentrations, use relevant data to predict experimental results, and ultimately build appropriate models to interpret such data. In pharmacokinetics, data are analyzed using a mathematical representation of a part or whole organism<sup><xref ref-type="bibr" rid="CR66">66</xref>&#8211;<xref ref-type="bibr" rid="CR68">68</xref></sup>. In fact, PK models show the movement and fate of a drug in a biological system after administration<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. Therefore, one of the most important methods used to guide lithium therapy is the population pharmacokinetic approach, which takes into account inter- and intra-individual variability in predicting lithium doses. Many studies have conducted in the field of PK<sup><xref ref-type="bibr" rid="CR68">68</xref>,<xref ref-type="bibr" rid="CR69">69</xref></sup>. Previous studies<sup><xref ref-type="bibr" rid="CR69">69</xref>,<xref ref-type="bibr" rid="CR70">70</xref></sup> were also benefited from pharmacokinetic modeling with less data than the data in this study. Thus, one of our main objectives was to create a database capable of supporting advanced lithium PK modeling and predictive analytics in future studies.</p><sec id="Sec13"><title>Limitations</title><p id="Par47">Adhering to ethical and legal considerations was a priority for this study. However, the process of obtaining approvals from the University of Medical Sciences, acquiring permits, and extracting patient data took approximately two years, delaying progress. Additional limitations included missing data, technological challenges in recording and collecting information, and inconsistencies in data recording across different periods. The lack of systematic blood and urine test recording before 2019 significantly reduced the volume of available data, limiting our analysis to post-2019 records.</p><p id="Par48">One of the limitations of this study was the inability to consider genetic factors due to the lack of facilities for obtaining such tests. However, an innovative approach for future studies would be to combine geographical, environmental, and familial factors with genetic data to explore their interrelationships. Although genetic data could not be obtained in this study, examining the aforementioned factors and referencing studies that have explored the relationship between these factors and genetics could provide valuable insights.</p></sec><sec id="Sec14"><title>Objectives</title><p id="Par49">The study aimed to extract, arrange, and pre-process a wide range of features to facilitate pharmacokinetic modeling using artificial intelligence in future studies. Given the challenges in extracting specific data, especially in Iran and other parts of the world, this study seeks to provide a robust dataset that can shorten and simplify modeling processes using machine learning techniques. Ultimately, this effort aims to reduce treatment duration, minimize costs, and enhance lithium concentration stability in patients with bipolar disorder.</p><p id="Par50">In collaboration with the Faculty of Engineering and the University of Medical Sciences, this study aimed to integrate engineering and medical perspectives. This interdisciplinary approach is expected to advance scientific and technological progress in understanding and treating bipolar disorders and other mental illnesses, which remain significant global health burdens.</p></sec><sec id="Sec15"><title>Future work</title><p id="Par51">Future studies will focus on leveraging artificial intelligence, data mining, supervised and unsupervised learning methods, and tools like RapidMiner and Python. These approaches will be combined with key PK parameters such as area under the curve (AUC) and area under the moment curve (AUMC) to develop advanced models for pattern recognition and lithium pharmacokinetics (<italic toggle="yes">First Iranian Study Evaluating Serum Levels of Lithium in Patients for Population Pharmacokinetics (FIRELOLIPOP)</italic>).</p></sec></sec><sec id="Sec25" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41598_2025_99698_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1.</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Mohammad Mahdi Khakshoor and Naser Pariz share the co-first authorships.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This research was undertaken with financial assistance from the research council of Mashhad University of Medical Sciences (4011114, IR.MUMS.MEDICAL.REC.1401.485, dated 2022&#8211;11&#8211;08).</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>M.M.K., N.P., V.R.A., M.R.FB., S.H., M.S., V.B.R., and M.B.NS., performed the experiments, wrote the paper, and designed the study. M.M.K., N.P., V.R.A., M.R.FB., S.H., M.S., V.B.R., and M.B.NS., contributed to writing the paper and analyzing the data. M.M.K., V.R.A., S.H., and M.S. performed the statistical analysis, prepared figures and/or tables, and contributed to the study&#8217;s design. M.R.FB., S.H., and M.S. performed clinical confirmation. M.M.K., N.P., V.R.A., M.R.FB., S.H., M.S., V.B.R., and M.B.NS., critically reviewed the manuscript. V.R.A. Supervised the whole study and approved the final version of the manuscript. All authors contributed to the article and approved the submitted version.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was made possible by an award from Mashhad University of Medical Sciences with grant number 4011114.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author (V.R.A.) upon reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par53">The authors declare no competing interests.</p></notes><notes id="FPar3"><title>Ethics approval</title><p id="Par55">Informed consent was obtained from all the patients.</p></notes><notes id="FPar6"><title>Informed consent</title><p id="Par58">has been received from Mashhad University of Medical Sciences Ethical Committee (Ethical permission code: IR.MUMS.MEDICAL.REC.1401.485, permission date: 2022&#8211;11&#8211;08, Approval ID: 4011114).</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanthorn-Hazell</surname><given-names>S</given-names></name><name name-style="western"><surname>Gracia</surname><given-names>A</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>J</given-names></name><name name-style="western"><surname>Boldeanu</surname><given-names>A</given-names></name><name name-style="western"><surname>Judge</surname><given-names>D</given-names></name></person-group><article-title>A survey of caregiver burden in those providing informal care for patients with schizophrenia or bipolar disorder with agitation: results from a European study</article-title><source>Ann. Gen. Psychiatry</source><year>2018</year><volume>17</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/s12991-018-0178-2</pub-id><pub-id pub-id-type="pmcid">PMC5810188</pub-id><pub-id pub-id-type="pmid">29456588</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Blanthorn-Hazell, S., Gracia, A., Roberts, J., Boldeanu, A. &amp; Judge, D. A survey of caregiver burden in those providing informal care for patients with schizophrenia or bipolar disorder with agitation: Results from a European study. <italic toggle="yes">Ann. Gen. Psychiatry</italic>. <bold>17</bold> (1), 1&#8211;7 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12991-018-0178-2</pub-id><pub-id pub-id-type="pmcid">PMC5810188</pub-id><pub-id pub-id-type="pmid">29456588</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grande</surname><given-names>I</given-names></name><name name-style="western"><surname>Berk</surname><given-names>M</given-names></name><name name-style="western"><surname>Birmaher</surname><given-names>B</given-names></name><name name-style="western"><surname>Vieta</surname><given-names>E</given-names></name></person-group><article-title>Bipolar disorder</article-title><source>Lancet</source><year>2016</year><volume>387</volume><issue>10027</issue><fpage>1561</fpage><lpage>1572</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(15)00241-X</pub-id><pub-id pub-id-type="pmid">26388529</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Grande, I., Berk, M., Birmaher, B. &amp; Vieta, E. Bipolar disorder. <italic toggle="yes">Lancet</italic><bold>387</bold> (10027), 1561&#8211;1572 (2016).<pub-id pub-id-type="pmid">26388529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(15)00241-X</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McIntyre</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Bipolar disorders</article-title><source>Lancet</source><year>2020</year><volume>396</volume><issue>10265</issue><fpage>1841</fpage><lpage>1856</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31544-0</pub-id><pub-id pub-id-type="pmid">33278937</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">McIntyre, R. S. et al. Bipolar disorders. <italic toggle="yes">Lancet</italic><bold>396</bold> (10265), 1841&#8211;1856 (2020).<pub-id pub-id-type="pmid">33278937</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)31544-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Global and national burden of 12 mental disorders in 204 countries and territories, 1990&#8211;2019: A systematic analysis for the Global Burden of Disease Study 2019. <italic toggle="yes">Lancet Psychiatry</italic>. <bold>9</bold> (2), 137&#8211;50. (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2215-0366(21)00395-3</pub-id><pub-id pub-id-type="pmcid">PMC8776563</pub-id><pub-id pub-id-type="pmid">35026139</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cipriani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis</article-title><source>Lancet</source><year>2011</year><volume>378</volume><issue>9799</issue><fpage>1306</fpage><lpage>1315</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)60873-8</pub-id><pub-id pub-id-type="pmid">21851976</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Cipriani, A. et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis. <italic toggle="yes">Lancet</italic><bold>378</bold> (9799), 1306&#8211;1315 (2011).<pub-id pub-id-type="pmid">21851976</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(11)60873-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miura</surname><given-names>T</given-names></name><etal/></person-group><article-title>Comparative efficacy and tolerability of Pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis</article-title><source>Lancet Psychiatry</source><year>2014</year><volume>1</volume><issue>5</issue><fpage>351</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/S2215-0366(14)70314-1</pub-id><pub-id pub-id-type="pmid">26360999</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Miura, T. et al. Comparative efficacy and tolerability of Pharmacological treatments in the maintenance treatment of bipolar disorder: A systematic review and network meta-analysis. <italic toggle="yes">Lancet Psychiatry</italic>. <bold>1</bold> (5), 351&#8211;359 (2014).<pub-id pub-id-type="pmid">26360999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2215-0366(14)70314-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Licht</surname><given-names>RW</given-names></name><name name-style="western"><surname>Lithium</surname></name></person-group><article-title>Still a major option in the management of bipolar disorder</article-title><source>CNS Neurosci. Ther.</source><year>2012</year><volume>18</volume><issue>3</issue><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1111/j.1755-5949.2011.00260.x</pub-id><pub-id pub-id-type="pmid">22070642</pub-id><pub-id pub-id-type="pmcid">PMC6493602</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Licht, R. W. &amp; Lithium Still a major option in the management of bipolar disorder. <italic toggle="yes">CNS Neurosci. Ther.</italic><bold>18</bold> (3), 219&#8211;226 (2012).<pub-id pub-id-type="pmid">22070642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1755-5949.2011.00260.x</pub-id><pub-id pub-id-type="pmcid">PMC6493602</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhi</surname><given-names>GS</given-names></name><name name-style="western"><surname>Tanious</surname><given-names>M</given-names></name></person-group><article-title>Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations</article-title><source>CNS Drugs</source><year>2011</year><volume>25</volume><fpage>289</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.2165/11586970-000000000-00000</pub-id><pub-id pub-id-type="pmid">21425882</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Malhi, G. S. &amp; Tanious, M. Optimal frequency of lithium administration in the treatment of bipolar disorder: Clinical and dosing considerations. <italic toggle="yes">CNS Drugs</italic>. <bold>25</bold>, 289&#8211;298 (2011).<pub-id pub-id-type="pmid">21425882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/11586970-000000000-00000</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Burton, M. E. <italic toggle="yes">Applied Pharmacokinetics &amp; Pharmacodynamics: Principles of Therapeutic Drug Monitoring</italic> (Lippincott Williams &amp; Wilkins, 2006).</mixed-citation></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gai</surname><given-names>M</given-names></name><etal/></person-group><article-title>Evaluation of the in vitro and in vivo performance of two sustained-release lithium carbonate matrix tablets. Effect of different diets on the bioavailability</article-title><source>Drug Dev. Ind. Pharm.</source><year>1999</year><volume>25</volume><issue>2</issue><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1081/DDC-100102153</pub-id><pub-id pub-id-type="pmid">10065346</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Gai, M. et al. Evaluation of the in vitro and in vivo performance of two sustained-release lithium carbonate matrix tablets. Effect of different diets on the bioavailability. <italic toggle="yes">Drug Dev. Ind. Pharm.</italic><bold>25</bold> (2), 131&#8211;140 (1999).<pub-id pub-id-type="pmid">10065346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1081/ddc-100102153</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Lehmann, K. Pharmakokinetik von Lithiurnsalzen. Die Lithiumtherapie: Nutzen&#183; Risiken&#183; Alternativen. 148&#8211;&#8201;60. (1997).</mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Bauer, A. <italic toggle="yes">L. Applied Clinical Pharmacokinetics</italic> (Mc Graw-Hill, 2008).</mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Couffignal, C., Chevillard, L., El Balkhi, S., Cisternino, S. &amp; Decl&#232;ves, X. The pharmacokinetics of lithium. The science and practice of lithium therapy. 25&#8211;53. (2017).</mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ward</surname><given-names>ME</given-names></name><name name-style="western"><surname>Musa</surname><given-names>MN</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>L</given-names></name></person-group><article-title>Clinical pharmacokinetics of lithium</article-title><source>J. Clin. Pharmacol.</source><year>1994</year><volume>34</volume><issue>4</issue><fpage>280</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1002/j.1552-4604.1994.tb01994.x</pub-id><pub-id pub-id-type="pmid">8006194</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ward, M. E., Musa, M. N. &amp; Bailey, L. Clinical pharmacokinetics of lithium. <italic toggle="yes">J. Clin. Pharmacol.</italic><bold>34</bold> (4), 280&#8211;285 (1994).<pub-id pub-id-type="pmid">8006194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/j.1552-4604.1994.tb01994.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Bauer, M., Grof, P. &amp; Muller-Oerlinghausen, B. <italic toggle="yes">Lithium in Neuropsychiatry: the Comprehensive Guide</italic> (Informa Health Care, 2006).</mixed-citation></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terhaag</surname><given-names>B</given-names></name><name name-style="western"><surname>Scherber</surname><given-names>A</given-names></name><name name-style="western"><surname>Schaps</surname><given-names>P</given-names></name><name name-style="western"><surname>Winkler</surname><given-names>H</given-names></name></person-group><article-title>The distribution of lithium into cerebrospinal fluid, brain tissue and bile in man</article-title><source>Int. J. Clin. Pharmacol. Biopharmacy</source><year>1978</year><volume>16</volume><issue>7</issue><fpage>333</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">669880</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Terhaag, B., Scherber, A., Schaps, P. &amp; Winkler, H. The distribution of lithium into cerebrospinal fluid, brain tissue and bile in man. <italic toggle="yes">Int. J. Clin. Pharmacol. Biopharmacy</italic>. <bold>16</bold> (7), 333&#8211;335 (1978).<pub-id pub-id-type="pmid">669880</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grandjean</surname><given-names>EM</given-names></name><name name-style="western"><surname>Aubry</surname><given-names>J-M</given-names></name><name name-style="western"><surname>Lithium</surname></name></person-group><article-title>Updated human knowledge using an evidence-based approach: part II: clinical Pharmacology and therapeutic monitoring</article-title><source>CNS Drugs</source><year>2009</year><volume>23</volume><fpage>331</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.2165/00023210-200923040-00005</pub-id><pub-id pub-id-type="pmid">19374461</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Grandjean, E. M., Aubry, J-M. &amp; Lithium Updated human knowledge using an evidence-based approach: Part II: Clinical Pharmacology and therapeutic monitoring. <italic toggle="yes">CNS Drugs</italic>. <bold>23</bold>, 331&#8211;349 (2009).<pub-id pub-id-type="pmid">19374461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00023210-200923040-00005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohandas</surname><given-names>E</given-names></name><name name-style="western"><surname>Rajmohan</surname><given-names>V</given-names></name></person-group><article-title>Lithium use in special populations</article-title><source>Indian J. Psychiatry</source><year>2007</year><volume>49</volume><issue>3</issue><fpage>211</fpage><pub-id pub-id-type="doi">10.4103/0019-5545.37325</pub-id><pub-id pub-id-type="pmid">20661390</pub-id><pub-id pub-id-type="pmcid">PMC2902097</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Mohandas, E. &amp; Rajmohan, V. Lithium use in special populations. <italic toggle="yes">Indian J. Psychiatry</italic>. <bold>49</bold> (3), 211 (2007).<pub-id pub-id-type="pmid">20661390</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0019-5545.37325</pub-id><pub-id pub-id-type="pmcid">PMC2902097</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trepiccione</surname><given-names>F</given-names></name><name name-style="western"><surname>Monster Christensen</surname><given-names>B</given-names></name></person-group><article-title>Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings</article-title><source>JN J. Nephrol.</source><year>2010</year><volume>23</volume><issue>6</issue><fpage>S43</fpage><pub-id pub-id-type="pmid">21170888</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Trepiccione, F. &amp; Monster Christensen, B. Lithium-induced nephrogenic diabetes insipidus: New clinical and experimental findings. <italic toggle="yes">JN J. Nephrol.</italic><bold>23</bold> (6), S43 (2010).<pub-id pub-id-type="pmid">21170888</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arancibia</surname><given-names>A</given-names></name><name name-style="western"><surname>Corvalan</surname><given-names>F</given-names></name><name name-style="western"><surname>Mella</surname><given-names>F</given-names></name><name name-style="western"><surname>Concha</surname><given-names>L</given-names></name></person-group><article-title>Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations</article-title><source>Int. J. Clin. Pharmacol. Therapy Toxicol.</source><year>1986</year><volume>24</volume><issue>5</issue><fpage>240</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">3089949</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Arancibia, A., Corvalan, F., Mella, F. &amp; Concha, L. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations. <italic toggle="yes">Int. J. Clin. Pharmacol. Therapy Toxicol.</italic><bold>24</bold> (5), 240&#8211;245 (1986).<pub-id pub-id-type="pmid">3089949</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Cooper, T. B., Simpson, G. M., Lee, J. H. &amp; Bergner, P-E-E. Evaluation of a slow-release lithium carbonate formulation. <italic toggle="yes">Am. J. Psychiatry</italic> (1978).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/ajp.135.8.917</pub-id><pub-id pub-id-type="pmid">665833</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Granneman</surname><given-names>GR</given-names></name><name name-style="western"><surname>Schneck</surname><given-names>DW</given-names></name><name name-style="western"><surname>Cavanaugh</surname><given-names>JH</given-names></name><name name-style="western"><surname>Witt</surname><given-names>GF</given-names></name></person-group><article-title>Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium</article-title><source>J. Clin. Psychiatry</source><year>1996</year><volume>57</volume><issue>5</issue><fpage>204</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">8626351</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Granneman, G. R., Schneck, D. W., Cavanaugh, J. H. &amp; Witt, G. F. Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium. <italic toggle="yes">J. Clin. Psychiatry</italic>. <bold>57</bold> (5), 204&#8211;206 (1996).<pub-id pub-id-type="pmid">8626351</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>C-F</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y-Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>OYP</given-names></name></person-group><article-title>Single dose Pharmacokinetic study of lithium in Taiwanese/Chinese bipolar patients</article-title><source>Aust. N. Z. J. Psychiatry</source><year>1998</year><volume>32</volume><issue>1</issue><fpage>133</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.3109/00048679809062720</pub-id><pub-id pub-id-type="pmid">9565195</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Lee, C-F., Yang, Y-Y. &amp; Hu, O. Y. P. Single dose Pharmacokinetic study of lithium in Taiwanese/Chinese bipolar patients. <italic toggle="yes">Aust. N. Z. J. Psychiatry</italic>. <bold>32</bold> (1), 133&#8211;136 (1998).<pub-id pub-id-type="pmid">9565195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00048679809062720</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunter</surname><given-names>R</given-names></name></person-group><article-title>Steady-state pharmacokinetics of lithium carbonate in healthy subjects</article-title><source>Br. J. Clin. Pharmacol.</source><year>1988</year><volume>25</volume><issue>3</issue><fpage>375</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.1988.tb03316.x</pub-id><pub-id pub-id-type="pmid">3129009</pub-id><pub-id pub-id-type="pmcid">PMC1386362</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Hunter, R. Steady-state pharmacokinetics of lithium carbonate in healthy subjects. <italic toggle="yes">Br. J. Clin. Pharmacol.</italic><bold>25</bold> (3), 375&#8211;380 (1988).<pub-id pub-id-type="pmid">3129009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2125.1988.tb03316.x</pub-id><pub-id pub-id-type="pmcid">PMC1386362</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>ElDesoky</surname><given-names>E</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>V</given-names></name><name name-style="western"><surname>Alorainy</surname><given-names>M</given-names></name><name name-style="western"><surname>Hamdi</surname><given-names>M</given-names></name><name name-style="western"><surname>Derendorf</surname><given-names>H</given-names></name></person-group><article-title>Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population Pharmacokinetic approach</article-title><source>Int. J. Clin. Pharmacol. Ther.</source><year>2008</year><volume>46</volume><issue>12</issue><fpage>617</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.5414/CPP46617</pub-id><pub-id pub-id-type="pmid">19049695</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">ElDesoky, E., Kumar, V., Alorainy, M., Hamdi, M. &amp; Derendorf, H. Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population Pharmacokinetic approach. <italic toggle="yes">Int. J. Clin. Pharmacol. Ther.</italic><bold>46</bold> (12), 617&#8211;626 (2008).<pub-id pub-id-type="pmid">19049695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5414/cpp46617</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Murphy, J. E. Clinical pharmacokinetics: ASHP; (2011).</mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>C</given-names></name></person-group><article-title>Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences</article-title><source>J. Psychiatry Neurosci.</source><year>2002</year><volume>27</volume><issue>2</issue><fpage>104</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">11944505</pub-id><pub-id pub-id-type="pmcid">PMC161639</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Henry, C. Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: Sex differences. <italic toggle="yes">J. Psychiatry Neurosci.</italic><bold>27</bold> (2), 104&#8211;107 (2002).<pub-id pub-id-type="pmid">11944505</pub-id><pub-id pub-id-type="pmcid">PMC161639</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhi</surname><given-names>GS</given-names></name><name name-style="western"><surname>Tanious</surname><given-names>M</given-names></name><name name-style="western"><surname>Das</surname><given-names>P</given-names></name><name name-style="western"><surname>Berk</surname><given-names>M</given-names></name></person-group><article-title>The science and practice of lithium therapy</article-title><source>Australian New. Z. J. Psychiatry</source><year>2012</year><volume>46</volume><issue>3</issue><fpage>192</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1177/0004867412437346</pub-id><pub-id pub-id-type="pmid">22391277</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Malhi, G. S., Tanious, M., Das, P. &amp; Berk, M. The science and practice of lithium therapy. <italic toggle="yes">Austral. New. Z. J. Psychiatry</italic>. <bold>46</bold> (3), 192&#8211;211 (2012).<pub-id pub-id-type="pmid">22391277</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0004867412437346</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alda</surname><given-names>M</given-names></name></person-group><article-title>Lithium in the treatment of bipolar disorder: Pharmacology and pharmacogenetics</article-title><source>Mol. Psychiatry</source><year>2015</year><volume>20</volume><issue>6</issue><fpage>661</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1038/mp.2015.4</pub-id><pub-id pub-id-type="pmid">25687772</pub-id><pub-id pub-id-type="pmcid">PMC5125816</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Alda, M. Lithium in the treatment of bipolar disorder: Pharmacology and pharmacogenetics. <italic toggle="yes">Mol. Psychiatry</italic>. <bold>20</bold> (6), 661&#8211;670 (2015).<pub-id pub-id-type="pmid">25687772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2015.4</pub-id><pub-id pub-id-type="pmcid">PMC5125816</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>L</given-names></name><name name-style="western"><surname>Zolezzi</surname><given-names>M</given-names></name><name name-style="western"><surname>Lewczyk</surname><given-names>A</given-names></name></person-group><article-title>An updated review of the optimal lithium dosage regimen for renal protection</article-title><source>Can. J. Psychiatry</source><year>2013</year><volume>58</volume><issue>10</issue><fpage>595</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1177/070674371305801009</pub-id><pub-id pub-id-type="pmid">24165107</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Carter, L., Zolezzi, M. &amp; Lewczyk, A. An updated review of the optimal lithium dosage regimen for renal protection. <italic toggle="yes">Can. J. Psychiatry</italic>. <bold>58</bold> (10), 595&#8211;600 (2013).<pub-id pub-id-type="pmid">24165107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/070674371305801009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Effect of age on the severity of chronic lithium poisoning</article-title><source>Clin. Toxicol. (Phila)</source><year>2020</year><volume>58</volume><issue>11</issue><fpage>1023</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1080/15563650.2020.1726376</pub-id><pub-id pub-id-type="pmid">32068433</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Chan, B. S. et al. Effect of age on the severity of chronic lithium poisoning. <italic toggle="yes">Clin. Toxicol. (Phila)</italic>. <bold>58</bold> (11), 1023&#8211;1027 (2020).<pub-id pub-id-type="pmid">32068433</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15563650.2020.1726376</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/mental-disorders">https://www.who.int/news-room/fact-sheets/detail/mental-disorders</ext-link></mixed-citation></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Livingstone</surname><given-names>C</given-names></name><name name-style="western"><surname>Rampes</surname><given-names>H</given-names></name></person-group><article-title>Lithium: a review of its metabolic adverse effects</article-title><source>J. Psychopharmacol.</source><year>2006</year><volume>20</volume><issue>3</issue><fpage>347</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1177/0269881105057515</pub-id><pub-id pub-id-type="pmid">16174674</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Livingstone, C. &amp; Rampes, H. Lithium: A review of its metabolic adverse effects. <italic toggle="yes">J. Psychopharmacol.</italic><bold>20</bold> (3), 347&#8211;355 (2006).<pub-id pub-id-type="pmid">16174674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0269881105057515</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Owen, J. S. &amp; Fiedler-Kelly, J. <italic toggle="yes">Introduction To Population Pharmacokinetic/pharmacodynamic Analysis with Nonlinear Mixed Effects Models</italic> (Wiley, 2014).</mixed-citation></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aarons</surname><given-names>L</given-names></name></person-group><article-title>Population pharmacokinetics: theory and practice</article-title><source>Br. J. Clin. Pharmacol.</source><year>1991</year><volume>32</volume><issue>6</issue><fpage>669</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.1991.tb03971.x</pub-id><pub-id pub-id-type="pmid">1768557</pub-id><pub-id pub-id-type="pmcid">PMC1368544</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Aarons, L. Population pharmacokinetics: Theory and practice. <italic toggle="yes">Br. J. Clin. Pharmacol.</italic><bold>32</bold> (6), 669&#8211;670 (1991).<pub-id pub-id-type="pmid">1768557</pub-id><pub-id pub-id-type="pmcid">PMC1368544</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Couffignal</surname><given-names>C</given-names></name><name name-style="western"><surname>Chevillard</surname><given-names>L</given-names></name><name name-style="western"><surname>El Balkhi</surname><given-names>S</given-names></name><name name-style="western"><surname>Cisternino</surname><given-names>S</given-names></name><name name-style="western"><surname>Decl&#232;ves</surname><given-names>X</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Malhi</surname><given-names>GS</given-names></name><name name-style="western"><surname>Masson</surname><given-names>M</given-names></name><name name-style="western"><surname>Bellivier</surname><given-names>F</given-names></name></person-group><article-title>The pharmacokinetics of Lithium</article-title><source>The Science and Practice of Lithium Therapy</source><year>2017</year><publisher-loc>Cham</publisher-loc><publisher-name>Springer International Publishing</publisher-name><fpage>25</fpage><lpage>53</lpage></element-citation><mixed-citation id="mc-CR36" publication-type="book">Couffignal, C., Chevillard, L., El Balkhi, S., Cisternino, S. &amp; Decl&#232;ves, X. The pharmacokinetics of Lithium. In: (eds Malhi, G. S., Masson, M. &amp; Bellivier, F.) The Science and Practice of Lithium Therapy 25&#8211;53 (Springer, 2017).</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barlattani</surname><given-names>T</given-names></name><etal/></person-group><article-title>The influence of PER3 VNTR genotypes on the age of onset in a group of bipolar I disorder patients: an exploratory study</article-title><source>Int. J. Bipolar Disorders</source><year>2024</year><volume>12</volume><issue>1</issue><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/s40345-024-00346-7</pub-id><pub-id pub-id-type="pmcid">PMC11239620</pub-id><pub-id pub-id-type="pmid">38992306</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Barlattani, T. et al. The influence of PER3 VNTR genotypes on the age of onset in a group of bipolar I disorder patients: An exploratory study. <italic toggle="yes">Int. J. Bipolar Disorders</italic>. <bold>12</bold> (1), 25 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40345-024-00346-7</pub-id><pub-id pub-id-type="pmcid">PMC11239620</pub-id><pub-id pub-id-type="pmid">38992306</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tredget</surname><given-names>J</given-names></name><name name-style="western"><surname>Kirov</surname><given-names>A</given-names></name><name name-style="western"><surname>Kirov</surname><given-names>G</given-names></name></person-group><article-title>Effects of chronic lithium treatment on renal function</article-title><source>J. Affect. Disord.</source><year>2010</year><volume>126</volume><issue>3</issue><fpage>436</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2010.04.018</pub-id><pub-id pub-id-type="pmid">20483164</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Tredget, J., Kirov, A. &amp; Kirov, G. Effects of chronic lithium treatment on renal function. <italic toggle="yes">J. Affect. Disord.</italic><bold>126</bold> (3), 436&#8211;440 (2010).<pub-id pub-id-type="pmid">20483164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jad.2010.04.018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barroilhet</surname><given-names>SA</given-names></name><name name-style="western"><surname>Ghaemi</surname><given-names>SN</given-names></name></person-group><article-title>When and how to use lithium</article-title><source>Acta Psychiatry. Scand.</source><year>2020</year><volume>142</volume><issue>3</issue><fpage>161</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1111/acps.13202</pub-id><pub-id pub-id-type="pmid">32526812</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Barroilhet, S. A. &amp; Ghaemi, S. N. When and how to use lithium. <italic toggle="yes">Acta Psychiatry. Scand.</italic><bold>142</bold> (3), 161&#8211;172 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/acps.13202</pub-id><pub-id pub-id-type="pmid">32526812</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yatham</surname><given-names>LN</given-names></name><etal/></person-group><article-title>Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations</article-title><source>Bipolar Disord.</source><year>2021</year><volume>23</volume><issue>8</issue><fpage>767</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1111/bdi.13135</pub-id><pub-id pub-id-type="pmid">34599629</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Yatham, L. N. et al. Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. <italic toggle="yes">Bipolar Disord.</italic><bold>23</bold> (8), 767&#8211;788 (2021).<pub-id pub-id-type="pmid">34599629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bdi.13135</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Severus</surname><given-names>W</given-names></name><etal/></person-group><article-title>What is the optimal serum lithium level in the long-term treatment of bipolar disorder&#8211;a review?</article-title><source>Bipolar Disord.</source><year>2008</year><volume>10</volume><issue>2</issue><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1111/j.1399-5618.2007.00475.x</pub-id><pub-id pub-id-type="pmid">18271901</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Severus, W. et al. What is the optimal serum lithium level in the long-term treatment of bipolar disorder&#8211;a review? <italic toggle="yes">Bipolar Disord.</italic><bold>10</bold> (2), 231&#8211;237 (2008).<pub-id pub-id-type="pmid">18271901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1399-5618.2007.00475.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhi</surname><given-names>GS</given-names></name><name name-style="western"><surname>Gershon</surname><given-names>S</given-names></name><name name-style="western"><surname>Outhred</surname><given-names>T</given-names></name><name name-style="western"><surname>Lithiumeter</surname></name></person-group><article-title>Version 2.0</article-title><source>Bipolar Disord.</source><year>2016</year><volume>18</volume><issue>8</issue><fpage>631</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1111/bdi.12455</pub-id><pub-id pub-id-type="pmid">28063207</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Malhi, G. S., Gershon, S., Outhred, T. &amp; Lithiumeter Version 2.0. <italic toggle="yes">Bipolar Disord.</italic><bold>18</bold> (8), 631&#8211;641 (2016).<pub-id pub-id-type="pmid">28063207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bdi.12455</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhi</surname><given-names>GS</given-names></name><name name-style="western"><surname>Gessler</surname><given-names>D</given-names></name><name name-style="western"><surname>Outhred</surname><given-names>T</given-names></name></person-group><article-title>The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines</article-title><source>J. Affect. Disord.</source><year>2017</year><volume>217</volume><fpage>266</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2017.03.052</pub-id><pub-id pub-id-type="pmid">28437764</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Malhi, G. S., Gessler, D. &amp; Outhred, T. The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines. <italic toggle="yes">J. Affect. Disord.</italic><bold>217</bold>, 266&#8211;280 (2017).<pub-id pub-id-type="pmid">28437764</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jad.2017.03.052</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems (10th Revision): Geneva: World Health Organization. (2019). <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://icd.who.int/browse10/2019/en">https://icd.who.int/browse10/2019/en</ext-link></mixed-citation></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmadi-Abhari</surname><given-names>S-A</given-names></name><etal/></person-group><article-title>Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study</article-title><source>BMC Psychiatry</source><year>2003</year><volume>3</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1186/1471-244X-3-4</pub-id><pub-id pub-id-type="pmid">12740023</pub-id><pub-id pub-id-type="pmcid">PMC161797</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Ahmadi-Abhari, S-A. et al. Risk factors of thyroid abnormalities in bipolar patients receiving lithium: A case control study. <italic toggle="yes">BMC Psychiatry</italic>. <bold>3</bold>, 1&#8211;5 (2003).<pub-id pub-id-type="pmid">12740023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-244X-3-4</pub-id><pub-id pub-id-type="pmcid">PMC161797</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Hashemi, J., KHEYRABADI, G. R. &amp; Movahedian, A. Lithium ratio in bipolar patients in Isfahan, Iran. (2006).</mixed-citation></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghanizadeh</surname><given-names>A</given-names></name><name name-style="western"><surname>OmraniSigaroodi</surname><given-names>M</given-names></name><name name-style="western"><surname>Javadpour</surname><given-names>A</given-names></name><name name-style="western"><surname>Dabbaghmanesh</surname><given-names>MH</given-names></name><name name-style="western"><surname>Shafiee</surname><given-names>S</given-names></name></person-group><article-title>Lovastatin as an adjuvant to Lithium for treating manic phase of bipolar disorder: A 4-Week, randomized, Double&#8208;Blind, Placebo&#8208;Controlled clinical trial</article-title><source>Depress. Res. Treat.</source><year>2014</year><volume>2014</volume><issue>1</issue><fpage>730505</fpage><pub-id pub-id-type="pmid">25132988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/730505</pub-id><pub-id pub-id-type="pmcid">PMC4123509</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Ghanizadeh, A., OmraniSigaroodi, M., Javadpour, A., Dabbaghmanesh, M. H. &amp; Shafiee, S. Lovastatin as an adjuvant to Lithium for treating manic phase of bipolar disorder: A 4-Week, randomized, Double&#8208;Blind, Placebo&#8208;Controlled clinical trial. <italic toggle="yes">Depress. Res. Treat.</italic><bold>2014</bold> (1), 730505 (2014).<pub-id pub-id-type="pmid">25132988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/730505</pub-id><pub-id pub-id-type="pmcid">PMC4123509</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Badrfam</surname><given-names>R</given-names></name><etal/></person-group><article-title>The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo&#8208;controlled, clinical trial</article-title><source>Brain Behav.</source><year>2021</year><volume>11</volume><issue>11</issue><fpage>e2394</fpage><pub-id pub-id-type="doi">10.1002/brb3.2394</pub-id><pub-id pub-id-type="pmid">34662000</pub-id><pub-id pub-id-type="pmcid">PMC8613435</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Badrfam, R. et al. The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; A double-blind, randomized, placebo&#8208;controlled, clinical trial. <italic toggle="yes">Brain Behav.</italic><bold>11</bold> (11), e2394 (2021).<pub-id pub-id-type="pmid">34662000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/brb3.2394</pub-id><pub-id pub-id-type="pmcid">PMC8613435</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zandifar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Efficacy of vitamins B1 and B6 as an adjunctive therapy to lithium in bipolar-I disorder: A double-blind, randomized, placebo-controlled, clinical trial</article-title><source>J. Affect. Disord.</source><year>2024</year><volume>345</volume><fpage>103</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2023.10.121</pub-id><pub-id pub-id-type="pmid">37866735</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Zandifar, A. et al. Efficacy of vitamins B1 and B6 as an adjunctive therapy to lithium in bipolar-I disorder: A double-blind, randomized, placebo-controlled, clinical trial. <italic toggle="yes">J. Affect. Disord.</italic><bold>345</bold>, 103&#8211;111 (2024).<pub-id pub-id-type="pmid">37866735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jad.2023.10.121</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ataei</surname><given-names>S</given-names></name><name name-style="western"><surname>Mahdian</surname><given-names>MR</given-names></name><name name-style="western"><surname>Ghaleiha</surname><given-names>A</given-names></name><name name-style="western"><surname>Matinnia</surname><given-names>N</given-names></name><name name-style="western"><surname>Nili-Ahmadabadi</surname><given-names>A</given-names></name></person-group><article-title>Silymarin improves thyroid function in Lithium-treated bipolar patients: A randomized, Double-blind, Placebo-controlled pilot study</article-title><source>Curr. Drug Therapy</source><year>2024</year><volume>19</volume><issue>3</issue><fpage>346</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.2174/1574885518666230710122712</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Ataei, S., Mahdian, M. R., Ghaleiha, A., Matinnia, N. &amp; Nili-Ahmadabadi, A. Silymarin improves thyroid function in Lithium-treated bipolar patients: A randomized, Double-blind, Placebo-controlled pilot study. <italic toggle="yes">Curr. Drug Therapy</italic>. <bold>19</bold> (3), 346&#8211;353 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akbarzadeh</surname><given-names>F</given-names></name><etal/></person-group><article-title>Personality profile and therapeutic response to lithium carbonate and sodium valproate in mania with psychotic features</article-title><source>Int. Clin. Psychopharmacol.</source><year>2022</year><volume>37</volume><issue>2</issue><fpage>54</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1097/YIC.0000000000000385</pub-id><pub-id pub-id-type="pmid">34908536</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Akbarzadeh, F. et al. Personality profile and therapeutic response to lithium carbonate and sodium valproate in mania with psychotic features. <italic toggle="yes">Int. Clin. Psychopharmacol.</italic><bold>37</bold> (2), 54&#8211;59 (2022).<pub-id pub-id-type="pmid">34908536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/YIC.0000000000000385</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akbarzadeh</surname><given-names>F</given-names></name><etal/></person-group><article-title>The effect of adding Curcumin to sodium valproate in treatment of patients with bipolar disorder in the acute phase of mania: A randomized double-blind clinical trial</article-title><source>Front. Psychiatry</source><year>2023</year><volume>14</volume><fpage>1068277</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2023.1068277</pub-id><pub-id pub-id-type="pmid">36816417</pub-id><pub-id pub-id-type="pmcid">PMC9932771</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Akbarzadeh, F. et al. The effect of adding Curcumin to sodium valproate in treatment of patients with bipolar disorder in the acute phase of mania: A randomized double-blind clinical trial. <italic toggle="yes">Front. Psychiatry</italic>. <bold>14</bold>, 1068277 (2023).<pub-id pub-id-type="pmid">36816417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpsyt.2023.1068277</pub-id><pub-id pub-id-type="pmcid">PMC9932771</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marmol</surname><given-names>F</given-names></name></person-group><article-title>Lithium: bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium</article-title><source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source><year>2008</year><volume>32</volume><issue>8</issue><fpage>1761</fpage><lpage>1771</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2008.08.012</pub-id><pub-id pub-id-type="pmid">18789369</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Marmol, F. Lithium: bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium. <italic toggle="yes">Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>. <bold>32</bold> (8), 1761&#8211;1771 (2008).<pub-id pub-id-type="pmid">18789369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pnpbp.2008.08.012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niemsiri</surname><given-names>V</given-names></name><etal/></person-group><article-title>Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis</article-title><source>Mol. Psychiatry</source><year>2024</year><volume>29</volume><issue>1</issue><fpage>6</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1038/s41380-022-01909-9</pub-id><pub-id pub-id-type="pmid">36991131</pub-id><pub-id pub-id-type="pmcid">PMC11078741</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Niemsiri, V. et al. Focal adhesion is associated with lithium response in bipolar disorder: Evidence from a network-based multi-omics analysis. <italic toggle="yes">Mol. Psychiatry</italic>. <bold>29</bold> (1), 6&#8211;19 (2024).<pub-id pub-id-type="pmid">36991131</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41380-022-01909-9</pub-id><pub-id pub-id-type="pmcid">PMC11078741</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhi</surname><given-names>GS</given-names></name><name name-style="western"><surname>Tanious</surname><given-names>M</given-names></name><name name-style="western"><surname>Das</surname><given-names>P</given-names></name><name name-style="western"><surname>Coulston</surname><given-names>CM</given-names></name><name name-style="western"><surname>Berk</surname><given-names>M</given-names></name></person-group><article-title>Potential mechanisms of action of lithium in bipolar disorder: current Understanding</article-title><source>CNS Drugs</source><year>2013</year><volume>27</volume><fpage>135</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1007/s40263-013-0039-0</pub-id><pub-id pub-id-type="pmid">23371914</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Malhi, G. S., Tanious, M., Das, P., Coulston, C. M. &amp; Berk, M. Potential mechanisms of action of lithium in bipolar disorder: Current Understanding. <italic toggle="yes">CNS Drugs</italic>. <bold>27</bold>, 135&#8211;153 (2013).<pub-id pub-id-type="pmid">23371914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40263-013-0039-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geddes</surname><given-names>JR</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name><name name-style="western"><surname>Hawton</surname><given-names>K</given-names></name><name name-style="western"><surname>Jamison</surname><given-names>K</given-names></name><name name-style="western"><surname>Goodwin</surname><given-names>GM</given-names></name></person-group><article-title>Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials</article-title><source>Am. J. Psychiatry</source><year>2004</year><volume>161</volume><issue>2</issue><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.161.2.217</pub-id><pub-id pub-id-type="pmid">14754766</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Geddes, J. R., Burgess, S., Hawton, K., Jamison, K. &amp; Goodwin, G. M. Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. <italic toggle="yes">Am. J. Psychiatry</italic>. <bold>161</bold> (2), 217&#8211;222 (2004).<pub-id pub-id-type="pmid">14754766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ajp.161.2.217</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheikh</surname><given-names>M</given-names></name><name name-style="western"><surname>Qassem</surname><given-names>M</given-names></name><name name-style="western"><surname>Triantis</surname><given-names>IF</given-names></name><name name-style="western"><surname>Kyriacou</surname><given-names>PA</given-names></name></person-group><article-title>Advances in therapeutic monitoring of lithium in the management of bipolar disorder</article-title><source>Sensors</source><year>2022</year><volume>22</volume><issue>3</issue><fpage>736</fpage><pub-id pub-id-type="doi">10.3390/s22030736</pub-id><pub-id pub-id-type="pmid">35161482</pub-id><pub-id pub-id-type="pmcid">PMC8838674</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Sheikh, M., Qassem, M., Triantis, I. F. &amp; Kyriacou, P. A. Advances in therapeutic monitoring of lithium in the management of bipolar disorder. <italic toggle="yes">Sensors</italic><bold>22</bold> (3), 736 (2022).<pub-id pub-id-type="pmid">35161482</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/s22030736</pub-id><pub-id pub-id-type="pmcid">PMC8838674</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kessing</surname><given-names>LV</given-names></name></person-group><article-title>Why is lithium [not] the drug of choice for bipolar disorder? A controversy between science and clinical practice</article-title><source>Int. J. Bipolar Disorders</source><year>2024</year><volume>12</volume><issue>1</issue><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/s40345-023-00322-7</pub-id><pub-id pub-id-type="pmcid">PMC10792154</pub-id><pub-id pub-id-type="pmid">38228882</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Kessing, L. V. Why is lithium [not] the drug of choice for bipolar disorder? A controversy between science and clinical practice. <italic toggle="yes">Int. J. Bipolar Disorders</italic>. <bold>12</bold> (1), 3 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40345-023-00322-7</pub-id><pub-id pub-id-type="pmcid">PMC10792154</pub-id><pub-id pub-id-type="pmid">38228882</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>L</given-names></name><etal/></person-group><article-title>Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study</article-title><source>Lancet</source><year>2016</year><volume>387</volume><issue>10023</issue><fpage>1085</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)00143-4</pub-id><pub-id pub-id-type="pmid">26806518</pub-id><pub-id pub-id-type="pmcid">PMC4814312</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Hou, L. et al. Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study. <italic toggle="yes">Lancet</italic><bold>387</bold> (10023), 1085&#8211;1093 (2016).<pub-id pub-id-type="pmid">26806518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(16)00143-4</pub-id><pub-id pub-id-type="pmcid">PMC4814312</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ochoa</surname><given-names>EL</given-names></name></person-group><article-title>Lithium as a neuroprotective agent for bipolar disorder: an overview</article-title><source>Cell. Mol. Neurobiol.</source><year>2022</year><volume>42</volume><issue>1</issue><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1007/s10571-021-01129-9</pub-id><pub-id pub-id-type="pmid">34357564</pub-id><pub-id pub-id-type="pmcid">PMC11441275</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Ochoa, E. L. Lithium as a neuroprotective agent for bipolar disorder: An overview. <italic toggle="yes">Cell. Mol. Neurobiol.</italic><bold>42</bold> (1), 85&#8211;97 (2022).<pub-id pub-id-type="pmid">34357564</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10571-021-01129-9</pub-id><pub-id pub-id-type="pmcid">PMC11441275</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cousins</surname><given-names>DA</given-names></name><name name-style="western"><surname>Squarcina</surname><given-names>L</given-names></name><name name-style="western"><surname>Boumezbeur</surname><given-names>F</given-names></name><name name-style="western"><surname>Young</surname><given-names>AH</given-names></name><name name-style="western"><surname>Bellivier</surname><given-names>F</given-names></name></person-group><article-title>Lithium: past, present, and future</article-title><source>Lancet Psychiatry</source><year>2020</year><volume>7</volume><issue>3</issue><fpage>222</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/S2215-0366(19)30365-7</pub-id><pub-id pub-id-type="pmid">31564465</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Cousins, D. A., Squarcina, L., Boumezbeur, F., Young, A. H. &amp; Bellivier, F. Lithium: Past, present, and future. <italic toggle="yes">Lancet Psychiatry</italic>. <bold>7</bold> (3), 222&#8211;224 (2020).<pub-id pub-id-type="pmid">31564465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2215-0366(19)30365-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volkmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Bschor</surname><given-names>T</given-names></name><name name-style="western"><surname>K&#246;hler</surname><given-names>S</given-names></name></person-group><article-title>Lithium treatment over the lifespan in bipolar disorders</article-title><source>Front. Psychiatry</source><year>2020</year><volume>11</volume><fpage>377</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2020.00377</pub-id><pub-id pub-id-type="pmid">32457664</pub-id><pub-id pub-id-type="pmcid">PMC7221175</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Volkmann, C., Bschor, T. &amp; K&#246;hler, S. Lithium treatment over the lifespan in bipolar disorders. <italic toggle="yes">Front. Psychiatry</italic>. <bold>11</bold>, 377 (2020).<pub-id pub-id-type="pmid">32457664</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpsyt.2020.00377</pub-id><pub-id pub-id-type="pmcid">PMC7221175</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhi</surname><given-names>GS</given-names></name></person-group><article-title>Lithium therapy in bipolar disorder: a balancing act?</article-title><source>Lancet</source><year>2015</year><volume>386</volume><issue>9992</issue><fpage>415</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)62123-1</pub-id><pub-id pub-id-type="pmid">26003378</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Malhi, G. S. Lithium therapy in bipolar disorder: A balancing act? <italic toggle="yes">Lancet</italic><bold>386</bold> (9992), 415&#8211;416 (2015).<pub-id pub-id-type="pmid">26003378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(14)62123-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Geddes, J. R. et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. <italic toggle="yes">Lancet</italic><bold>375</bold>(9712). (2009).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(09)61828-6</pub-id><pub-id pub-id-type="pmid">20092882</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKnight</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Lithium toxicity profile: a systematic review and meta-analysis</article-title><source>Lancet</source><year>2012</year><volume>379</volume><issue>9817</issue><fpage>721</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)61516-X</pub-id><pub-id pub-id-type="pmid">22265699</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">McKnight, R. F. et al. Lithium toxicity profile: A systematic review and meta-analysis. <italic toggle="yes">Lancet</italic><bold>379</bold> (9817), 721&#8211;728 (2012).<pub-id pub-id-type="pmid">22265699</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(11)61516-X</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wagner</surname><given-names>JG</given-names></name></person-group><article-title>History of pharmacokinetics</article-title><source>Pharmacol. Ther.</source><year>1981</year><volume>12</volume><issue>3</issue><fpage>537</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/0163-7258(81)90097-8</pub-id><pub-id pub-id-type="pmid">7025032</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Wagner, J. G. History of pharmacokinetics. <italic toggle="yes">Pharmacol. Ther.</italic><bold>12</bold> (3), 537&#8211;562 (1981).<pub-id pub-id-type="pmid">7025032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0163-7258(81)90097-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="other">Rescigno, A. <italic toggle="yes">Foundations of Pharmacokinetics</italic> (Springer, 2003).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/phrs.2000.0718</pub-id><pub-id pub-id-type="pmid">11058404</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herrero</surname><given-names>P</given-names></name><etal/></person-group><article-title>Closed-loop control for precision antimicrobial delivery: an in Silico proof-of-concept</article-title><source>IEEE Trans. Biomed. Eng.</source><year>2017</year><volume>65</volume><issue>10</issue><fpage>2231</fpage><lpage>2236</lpage><pub-id pub-id-type="doi">10.1109/TBME.2017.2787423</pub-id><pub-id pub-id-type="pmid">29989937</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Herrero, P. et al. Closed-loop control for precision antimicrobial delivery: An in Silico proof-of-concept. <italic toggle="yes">IEEE Trans. Biomed. Eng.</italic><bold>65</bold> (10), 2231&#8211;2236 (2017).<pub-id pub-id-type="pmid">29989937</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/TBME.2017.2787423</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Couffignal</surname><given-names>C</given-names></name><etal/></person-group><article-title>Population Pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder</article-title><source>Eur. J. Clin. Pharmacol.</source><year>2019</year><volume>75</volume><fpage>519</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1007/s00228-018-2605-3</pub-id><pub-id pub-id-type="pmid">30554270</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Couffignal, C. et al. Population Pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder. <italic toggle="yes">Eur. J. Clin. Pharmacol.</italic><bold>75</bold>, 519&#8211;528 (2019).<pub-id pub-id-type="pmid">30554270</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00228-018-2605-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Wang C-y. Population pharmacokinetics and dosing regimen of lithium in Chinese patients with bipolar disorder</article-title><source>Front. Pharmacol.</source><year>2022</year><volume>13</volume><fpage>913935</fpage><pub-id pub-id-type="doi">10.3389/fphar.2022.913935</pub-id><pub-id pub-id-type="pmid">35860024</pub-id><pub-id pub-id-type="pmcid">PMC9289112</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Jin, Z. et al. Wang C-y. Population pharmacokinetics and dosing regimen of lithium in Chinese patients with bipolar disorder. <italic toggle="yes">Front. Pharmacol.</italic><bold>13</bold>, 913935 (2022).<pub-id pub-id-type="pmid">35860024</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2022.913935</pub-id><pub-id pub-id-type="pmcid">PMC9289112</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>